Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
EP1.17 - Treatment of Early Stage/Localized Disease
- 08:00 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Treatment of Early Stage/Localized Disease
-
+
EP1.17-01 - Surgical Resection of Synchronous Quadruple Primary Lung Tumors Present as Three-Different Cancers and One Benign Mass
08:00 - 08:00 | Presenter: Yongjik Lee | Author(s): Su Kyung Hwang, Gwan Sic Kim, Hee Jeoung Cha
- Abstract
Loading... -
+
EP1.17-02 - Artificial Intelligence in the Qualitative Study of Pulmonary Nodules by Analyzing the Genetic Map and Imaging Data of Lung Adenocarcinoma
08:00 - 08:00 | Presenter: Yu Zhang
- Abstract
Loading... -
+
EP1.17-03 - New Approach to Complete Video-Assisted Thoracoscopic Lobectomy in T2 and T3 Non-Small Cell Lung Cancer
08:00 - 08:00 | Presenter: Masato Kato
- Abstract
Loading... -
+
EP1.17-04 - Pneumonectomy Should Be Avoided in Patients Who Do Not Reach the Distance of 500 Meters in 6-Minute Walking Test Due to High Early Mortality
08:00 - 08:00 | Presenter: Tomasz Marjanski | Author(s): Damian Wnuk, Robert Dziedzic, Marcin Ostrowski, Wioletta Sawicka, Witold Rzyman
- Abstract
Loading... -
+
EP1.17-05 - Uniportal Video-Assisted Thoracoscopic Surgery Lobectomy and Segmentectomy for Early Stage Lung Cancer
08:00 - 08:00 | Presenter: Runlei Hu
- Abstract
Loading... -
+
EP1.17-06 - Retrospective Review of Initial Experience of Robot-Assisted Left Upper Lobectomy for Lung Cancer in an Attempt to Standardize Its Procedure
08:00 - 08:00 | Presenter: Aya Yamamoto
- Abstract
Loading... -
+
EP1.17-07 - Partial Anomalous Pulmonary Venous Connection Found During a Lobectomy for Lung Cancer
08:00 - 08:00 | Presenter: Fumi Yokote | Author(s): Yoshikane Yamauchi, takashi Sakai, Yuichi Saito, Hirofumi Uehara, Yukinori Sakao, Masafumi Kawamura
- Abstract
Loading... -
+
EP1.17-08 - Good Survival in Females Undergoing Surgery Without Adjuvant Chemotherapy for Stage Three Lung Cancer: A Review of Our 12-Year Experience
08:00 - 08:00 | Presenter: Jianye Chen | Author(s): Harish Mithiran Muthiah
- Abstract
Loading... -
+
EP1.17-09 - Survival Analysis of 911 Patients with Surgically Resected Lung Cancers
08:00 - 08:00 | Presenter: Jun Zhang | Author(s): Ning Chen, Juan Qi, Qin Liu, Baosen Zhou, Xueshan Qiu
- Abstract
Loading... -
+
EP1.17-10 - First Results of the Bronchial Cancer Registry of the Thoracic Oncology Intergroup (IGOT) of Casablanca, Morocco
08:00 - 08:00 | Presenter: Souheil Boubia | Author(s): Sara Waguaf, Najat Idelhaj, Mohamed Ridai
- Abstract
Loading... -
+
EP1.17-11 - Non-Small Cell Lung Cancer Survival: Gender Inequality After Lung Resection?
08:00 - 08:00 | Presenter: Maria Teresa Tsukazan | Author(s): Alvaro Vigo, Jayme Rios, Airton Schneider, Joao Rafael Schmitt, Thomas Lima, Rayssa Ruszkowski, Paulo Alfredo Schulze, Jose Figueiredo Pinto
- Abstract
Loading... -
+
EP1.17-12 - Multimodal Aggressive Managment for Askin' Tumor: Results and Prognosis About 3 Cases
08:00 - 08:00 | Presenter: ihsan Alloubi | Author(s): SAID Afqir, ALI Sbai
- Abstract
Loading... -
+
EP1.17-13 - Operated Stages I-IIIB NSCLC Among Young Indian Cohorts - Clinical Profile and Outcomes
08:00 - 08:00 | Presenter: Jyoutishman Saikia | Author(s): Prabhat Singh Malik, Karan Madan, Deepali Jain, Sachidanand Jee Bharati, Manoj Gowda, Sourabh Nandi, S.V.S. Deo, SUNIL Kumar
- Abstract
Loading... -
+
EP1.17-14 - Less Is More: An Unusual Case of Benign Emptying of the Post - Pneumonectomy Space
08:00 - 08:00 | Presenter: Giovanni Bocchialini | Author(s): Cesare Braggio, Luigi Ventura, Matteo Pagani, Paolo Carbognani, Michele Rusca, Luca Ampollini
- Abstract
Loading... -
+
EP1.17-15 - Comparison of Long-Term Outcome of Wedge Resection, Anatomical Segmentectomy and Lobectomy in Stage I-II Non-Small Cell Lung Cancer
08:00 - 08:00 | Presenter: Katharina Sinn | Author(s): Elisabeth Gschwandtner, Ariane Steindl, Shahrokh Taghavi, Walter Klepetko, Thomas Klikovits, Mir Alireza Hoda
- Abstract
Loading... -
+
EP1.17-16 - Ultra-Small Lung Cancer (≤0.5cm) Is Facing Dilemma Situation of Over-Resection
08:00 - 08:00 | Presenter: Jun Zhang | Author(s): Ning Chen, Baosen Zhou, Xueshan Qiu
- Abstract
Loading... -
+
EP1.17-17 - Feasibility Study on the Central of Massive Lesion in Non-Small Cell Lung Cancer with High-Dose Radiotherapy
08:00 - 08:00 | Presenter: Jiancheng Li
- Abstract
Loading... -
+
EP1.17-18 - Neutrophil Count Is Non-Prognostic in Early Stage Lung Cancer Treated with SABR: Retrospective Analysis from a Single UK Centre Cohort
08:00 - 08:00 | Presenter: Tamasin Evans | Author(s): Karen Mactier, Ashley William Budden Horne, Allan Price, Sorcha Campell, Felicity Little, iain Phillips
- Abstract
Loading... -
+
EP1.17-19 - Robotic-Assisted Thoracic Surgery for Early Stage Lung Cancer: Ten Years' Single Institution Experience
08:00 - 08:00 | Presenter: Domenico Galetta | Author(s): Monica Casiraghi, Lorenzo Spaggiari
- Abstract
Loading... -
+
EP1.17-20 - Influence of Insurance Status on Survival of Patients with Non-Small Cell Lung Cancer Underwent Surgical Treatment
08:00 - 08:00 | Presenter: Yoohwa Hwang | Author(s): Hyeon Jong Moon, Mi Sun Shin
- Abstract
Loading... -
+
EP1.17-21 - Early Stage NSCLC (ES-NSCLC) 5-Fraction Stereotactic Body Radiation Therapy (SBRT) 3-Year Patterns of Failure
08:00 - 08:00 | Presenter: Rebecca Krochmal | Author(s): Nima Aghdam, Shaan Kataria, Monica Pernia, Clare Hall, Timothy O’connor, Lloyd Campbell, Simeng Suy, Sean P. Collins, Jonathan W. Lischalk, Eric R Anderson, Brian T. Collins
- Abstract
Loading... -
+
EP1.17-22 - In Stage I Non-Small Cell Lung Cancer, Abutting Adjacent Structures Is a Possible Prognostic Factor
08:00 - 08:00 | Presenter: Jaeshin Yoon | Author(s): Soohwan Choi, Deog Gon Cho, Seungkeun Yoon
- Abstract
Loading... -
+
EP1.17-23 - Omentopexy for Post-Pneumonectomy Bronchopleural Fistula in Patients with Non-Small Cell Lung Cancer After Salvage Radiotherapy
08:00 - 08:00 | Presenter: Deog Gon Cho | Author(s): Soohwan Choi, Hyung Soon Park, Gyurim Heo, Yongjin Chang
- Abstract
Loading... -
+
EP1.17-24 - Biologically Effective Dose Was Associated with Overall Survival in Stereotactic Body Radiotherapy for Lung Tumors
08:00 - 08:00 | Presenter: Osamu Tanaka | Author(s): Norihiko Funaguchi, Sayaka Toyoshi, Takuya Taniguchi, Kousei Ono, Yuka Kunishima, Yui Masui, Masayuki Matsuo
- Abstract
Loading... -
+
EP1.17-25 - Radio-Guided Localization of Small Lung Nodules
08:00 - 08:00 | Presenter: Samuel Garcia-Reina | Author(s): Esther Fernandez-Araujo, Sergio Lafuente, Victor Margeli, Isabel Nogueira, Marta Lacambra, Carlos Martinez-Barenys, Pedro E Lopez De Castro
- Abstract
Loading... -
+
EP1.17-26 - Spontaneous Right Contralateral Total Pneumothorax in Bullous Lung After Left Pneumonectomy for Lung Cancer
08:00 - 08:00 | Presenter: Fadil Gradica | Author(s): Lutfi Lisha, Dhimitraq Argjiri, Alma Cani, Fahri Kokici, Sali Gradica, Aishe Lala, Kleon Sali Gradica, Leon Shpataraku, Gulam Quadir
- Abstract
Loading... -
+
EP1.17-27 - Development of Titanium Alloy Vascular Mirror Forceps for Uniportal VATS
08:00 - 08:00 | Presenter: Junichi Shimada | Author(s): Kazuhiro Ito
- Abstract
Loading... -
+
EP1.17-28 - Electromagnetic Navigation-Guided Preoperative Localization for Small Malignant Pulmonary Tumors
08:00 - 08:00 | Presenter: Po-Kuei Hsu | Author(s): Yu-Chung Wu
- Abstract
Loading... -
+
EP1.17-29 - Evaluation of the Influence of Removed Lymph Nodes during VATS-Lobectomy in the Group of Patients with Early Stage of NSCLC on Long-Term Results
08:00 - 08:00 | Presenter: Dariusz Adam Dziedzic | Author(s): Grabczan Wojciech, Rudzinski Piotr, Renata Langfort, Tadeusz Orlowski
- Abstract
Loading... -
+
EP1.17-30 - Experience of Uniportal Video-Assisted Thoracoscopic Surgery in a Japanese General Hospital
08:00 - 08:00 | Presenter: Futoshi Ishiguro | Author(s): Hirohumi Takenaka, Naruaki Kawasaki, Kikuo Shigemitsu
- Abstract
Loading... -
+
EP1.17-31 - 30 Days Major Morbidity and Mortality After Lung Cancer Surgery. Outcomes of Five Years in a Single Center Experience
08:00 - 08:00 | Presenter: Fatmir Caushi | Author(s): Daniela Xhemalaj, Ilir Skenduli, Silvana Bala, Rajmonda Isufi, Arian Mezini, Hasan Hafizi, Ornela Nuredini, Alban Hatibi, Alma Cani
- Abstract
Loading... -
+
EP1.17-32 - Long-Term Outcomes of Pulmonary Resection for Lung Cancer Patients with Chronic Kidney Disease
08:00 - 08:00 | Presenter: Yoko Yamamoto | Author(s): Ryu Kanzaki, Takashi Kanou, Naoko Ose, Soichiro Funaki, Masato Minami, Yasushi Shintani
- Abstract
Loading... -
+
EP1.17-33 - Predictors of Air-Related Complication and Re-Intervention After Pleural Drainage Tube Removal in Digital Thoracic Drainage System Use
08:00 - 08:00 | Presenter: YiYing Lee
- Abstract
Loading... -
+
EP1.17-34 - Association Between the Number of Resected Lymph Nodes and Long-Term Survival in N0 Non-Small Cell Lung Cancer: Data from a Chinese Large Cohort
08:00 - 08:00 | Presenter: Hao-Xian Yang | Author(s): Mu-Zi Yang, Jing-Sheng Cai, Jie Yang, Shuo Li, Hao Long, Jian-Hua Fu, Lan-Jun Zhang, Peng Lin, Xin Wang, Tie-Hua Rong
- Abstract
Loading... -
+
EP1.17-35 - CBCT Radiomics May Predict Short-Term SBRT Effect in Early Stage Lung Cancer Patients
08:00 - 08:00 | Presenter: Liqiao Hou | Author(s): Chao Zhou, Yunyu Xu, Yinnan Meng, Changhui Yu, Feng-Ming Spring Kong, Haihua Yang
- Abstract
Loading... -
+
EP1.17-36 - Skin Fluorescence Following Photodynamic Therapy with Talaporfin Sodium
08:00 - 08:00 | Presenter: Sachio Maehara | Author(s): shunsuke Sigehuku, hideyuki Hurumoto, Yujin Kudo, youjiro Makino, Yoshihisa Shimada, Hagiwara Masaru, Masatoshi Kakihana, Tatsuo Ohira, Naohiro Kajiwara, Norihiko Ikeda
- Abstract
No abstract available for this presentation
-
+
EP1.18 - Treatment of Locoregional Disease - NSCLC
- 08:00 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Treatment of Locoregional Disease - NSCLC
-
+
EP1.18-01 - Effectiveness of Video-Assisted Surgery and Pre-Operative Multi-Disciplinary Support for Preserving Respiratory Function
08:00 - 08:00 | Presenter: Masafumi Kataoka | Author(s): Daisuke Okutani, Hruyuki Kawai, Kazuhiko Watanabe, Singo Harita, Miwa Baba, Tamami Okutani, Toshihiko Fujita, Kanto Suemori
- Abstract
Loading... -
+
EP1.18-02 - Pattern of Postoperative Recurrence and Clinical Value of Adjuvant Radiotherapy in Completely Resected Stage III/N2 EGFR-Mutant NSCLC
08:00 - 08:00 | Presenter: Jianjiao Ni | Author(s): tiantian Guo, Yuan Li, Zhengfei Zhu
- Abstract
Loading... -
+
EP1.18-03 - Outcome of Surgical Resection for Invasive Mucinous Adenocarcinoma: Experience at a Single Institution
08:00 - 08:00 | Presenter: Seiji Omura | Author(s): Noriko Motoi, Yukihiro Yoshida, Kazuo Nakagawa, Shun-ichi Watanabe
- Abstract
Loading... -
+
EP1.18-04 - Do Tumor-Related Factors Predict Postoperative Pulmonary Complications in Patients Undergoing Curative Surgery for Lung Cancer?
08:00 - 08:00 | Presenter: Ruslan Litvinyak | Author(s): Nazar Lukavetskyy, Ihor Hipp
- Abstract
Loading... -
+
- Abstract
Loading... -
+
EP1.18-06 - Results of Cytoreductive Wedge Resection of the Primary Site in Multidisciplinary Treatment of Stage III Non-Small Cell Lung Cancer
08:00 - 08:00 | Presenter: Michihito Toda | Author(s): Aya Yamamoto, Takashi Iwata
- Abstract
Loading... -
+
EP1.18-07 - Evaluation of Patient Outcomes Using Haematological Bio-Markers in Patients Undergoing Chemoradiation for Non Small Cell Lung Cancer
08:00 - 08:00 | Presenter: Tamasin Evans | Author(s): Ashley William Budden Horne, Karen Mactier, Hannah Hayhurst, iain Phillips, Allan Price, Sorcha Campell, Felicity Little, Ailsha Tufail, Kirsty Maclennan
- Abstract
Loading... -
+
EP1.18-08 - Pulmonary Lobectomy and Completion Pneumonectomy for Ipsilateral Lung Cancer After Radical Resection
08:00 - 08:00 | Presenter: Mikio Okazaki | Author(s): Ken Suzawa, Kentaroh Miyoshi, Shinji Otani, Hiromasa Yamamoto, Seiichiro Sugimoto, Masaomi Yamane, Takahiro Oto, Shinichi Toyooka
- Abstract
Loading... -
+
EP1.18-09 - Analysis of the Role of Postoperative Radiotherapy in Pathological N2 Non-Small Cell Lung Cancer with Propensity Score Matching
08:00 - 08:00 | Presenter: Jiancheng Li | Author(s): Liyu Su
- Abstract
Loading... -
+
EP1.18-10 - Bilateral Mediastinal Lymphadenectomy Is Associated with Better Survival in Stage IA-IIIB Non-Small Cell Lung Cancer
08:00 - 08:00 | Presenter: Akif Turna | Author(s): Hasan Volkan Kara, Melek Agkoç, Berat Sözen, Mehlika İşcan, Ezel Erşen, Kamil Kaynak
- Abstract
Loading... -
+
EP1.18-11 - Pancost Tumor: Feasibility of Minimally Invasive Approach
08:00 - 08:00 | Presenter: Daniel Sammartino Brandao | Author(s): Flavio Brito, Marcos Alexandre Balieiro, Eduardo de Souza Ponzio
- Abstract
Loading... -
+
EP1.18-12 - The Neutrophil and Platelet to Lymphocyte Ratios and Glasgow Prognostic Score as a Predictor for Relapse After Stereotactic Radiation for Lung Cancer
08:00 - 08:00 | Presenter: Janna Berg | Author(s): Morten Lindberg, May-Bente Bengtson, Odd Terje Brustugun, Åslaug Helland
- Abstract
Loading... -
+
EP1.18-13 - Review of Preoperative Examination
08:00 - 08:00 | Presenter: Fumihiko Hoshi | Author(s): Akira Sakurada, Masafumi Noda, Tetsu Sado, Yasushi Matsuda, Hisashi Oishi, Hirotsugu Notsuda, Takashi Hirama, Shunsuke Eba, Hiroshi Yabuki, Masato Katahira, Yamato Suzuki, Kotaro Abe, Kimiaki Sato, Hiroshi Katsumata, Hiroki Oshio, Takehiro Yamada, Yoshinori Okada
- Abstract
Loading... -
+
EP1.18-14 - Algorithm for Deciding Radiotherapy Technique in Stage III Non-Small Cell Lung Cancer
08:00 - 08:00 | Presenter: Namrata Das | Author(s): Rakesh Kapoor, Ashwani Sood, Arun Oinam, Raviteja Miriyala, Navneet Singh
- Abstract
Loading... -
+
EP1.18-15 - Surgical Results of Primary Mucoepidermoid Carcinoma of Lungs: A 9 Years' Experience
08:00 - 08:00 | Presenter: Tung Ming Tsai | Author(s): Mong-Wei Lin, Hsao-Hsun Hsu, Jin-Shing Chen
- Abstract
Loading... -
+
EP1.18-16 - Surgery for Locally Advanced Lung Cancer Invading the Spine After Chemoradiotherapy
08:00 - 08:00 | Presenter: Kohei Matsuda | Author(s): Kaoru Kaseda, Kyohei Masai, Keisuke Asakura, Tomoyuki Hishida, Hisao Asamura
- Abstract
Loading... -
+
EP1.18-17 - Pre-Radical Radiotherapy Plasma EGFR DNA Levels in Lung Cancer Patients May Predict for Early Disease Progression
08:00 - 08:00 | Presenter: Brendan Seng Hup Chia | Author(s): Wen Long Nei, Kam Weng Fong, Swee Peng Yap, Kevin Chua, Connie Yip, Wee Loon Ng, Tian Rui Siow, Min-Han Tan
- Abstract
Loading... -
+
EP1.18-18 - Body Shape and Tissue Composition Influences Uniform Distribution of Tumor Treating Fields Intensity Delivered to the Lungs
08:00 - 08:00 | Presenter: Uri Weinberg | Author(s): Noa Urman, Ze'ev Bomzon, Hadas Sarah Hershkovich, Eilon D Kirson, Yoram Palti
- Abstract
Loading... -
+
EP1.18-19 - Patients with Unresectable Stage III Non-Small Cell Lung Cancer Eligible to Receive Durvalumab in Clinical Practice
08:00 - 08:00 | Presenter: Kazuki Furuhashi | Author(s): Osamu Hataji, Yuki Nakamura, Yuta Suzuki, Tadashi Sakaguchi, Kentaro Ito, Kentaro Fujiwara, Yoichi Nishii, Osamu Taguchi
- Abstract
Loading... -
+
EP1.18-20 - Sleeve Lobectomy for Centrally Located Non-Small Cell Lung Cancer: Initial Short-Term Results from a Single Institute in Northeast China
08:00 - 08:00 | Presenter: Hong-Xu Liu | Author(s): Yegang Ma, Zhanwu Yu, Chenlei Zhang, Gebang Wang, Hongxi Liu, Guan Wang
- Abstract
Loading... -
+
EP1.18-22 - A Randomized Prospective Study Comparing Concomitant CRT Using Paclitaxel-Carboplatin and Etoposide-Cisplatin in Locally Advanced NSCLC
08:00 - 08:00 | Presenter: Srinivasa G Y
- Abstract
Loading... -
+
EP1.18-23 - Is Salvage Lung Resection Necessary After Definitive Chemoradiation Therapy for Stage IIIA(N2) Non-Small Cell Lung Cancer?
08:00 - 08:00 | Presenter: Akif Turna | Author(s): Hüseyin Melek, Melek Agkoç, Cengiz Gebitekin, Hande Turna, Fazilet Dinçbaş, Serdar Erturan, Günay Aydın, Kamil Kaynak
- Abstract
Loading... -
+
EP1.18-24 - Novel Technique - Mini Port Thoracoscopic Approach and Enhanced Recovery After Surgery for Treatment of Lung Cancer
08:00 - 08:00 | Presenter: Li Wentao | Author(s): Natasha Toleska Dimitrovska
- Abstract
Loading... -
+
EP1.18-25 - Definitive Radiotherapy in Lung Cancer – A Glimpse Over the Narrow Window
08:00 - 08:00 | Presenter: Arun Thimmarayappa | Author(s): Sushmita Pathy, Prabhat Singh Malik, SUNIL Kumar
- Abstract
Loading... -
+
EP1.18-26 - Treatment Patterns and Clinical Outcomes in Locally Advanced Non Small Cell Lung Cancer: Experience from Tertiary Care Centre
08:00 - 08:00 | Presenter: Sushmita Pathy | Author(s): Arun Thimmarayappa, Prabhat Singh Malik
- Abstract
Loading... -
+
EP1.18-27 - Study of Five Cases Resected Pulmonary Pleomorphic Carcinoma - Immune Checkpoint Inhibitors Are Improved the Prognosis?
08:00 - 08:00 | Presenter: Osamu Kawamata
- Abstract
Loading... -
+
EP1.18-28 - Neoadjuvant Therapy Among Patients Undergoing Resection for Non-Small-Cell Lung Cancer: A Single Institution Experience
08:00 - 08:00 | Presenter: Laura Gutiérrez Sainz | Author(s): Patricia Cruz, Julia Villamayor, Sergio Martínez Recio, Isabel Esteban, Francisco Arias Lotto, David Viñal, Dario Sanchez Cabrero, Oliver Higuera, Javier De Castro Carpeno
- Abstract
Loading... -
+
EP1.18-29 - Survival of Patients with Non-Small Cell Lung Cancer That Has Single Station Lymph Node Metastasis of 4R or 10R After Surgical Treatment
08:00 - 08:00 | Presenter: Ozgur Samancilar | Author(s): Ahmet Ucvet, Serkan Yazgan, Soner Gursoy
- Abstract
Loading... -
+
EP1.18-30 - A Case of Resected Primary Lung Cancer with Interlobar Dissemination
08:00 - 08:00 | Presenter: Daishiro Kato | Author(s): Atsuki Uchibori, Naoko Takeda, Takayuki Takeda
- Abstract
Loading... -
+
EP1.18-31 - Miniport Video-Assisted Thoracic Surgery Technique - A New Minimal Invasive Approach for Treatment of Lung Cancer: Case Report
08:00 - 08:00 | Presenter: Li Wentao | Author(s): Natasha Toleska Dimitrovska
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P1.01-01 - Clinical Relevance of Targeting Proteins Required for Mitotic Progression to Improve Chemotherapy Response in Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Mark Adams | Author(s): Joshua Burgess, Derek Richard, Kenneth John O’Byrne
- Abstract
Loading... -
+
P1.01-02 - Pemetrexed-Carboplatin Versus Paclitaxel (Weekly)-Carboplatin as First Line Chemotherapy in Advanced Non-Squamous NSCLC
09:45 - 09:45 | Presenter: Prabhat Singh Malik | Author(s): Ajay Yadav, Deepali Jain, Sushmita Pathy, Anant Mohan, SACHIN Khurana, Sachin Kumar
- Abstract
Loading... -
+
P1.01-03 - Efficacy and Safety of Biosimilar QL1101 Compared with Avastin in Patients with Non-Squamous Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Baohui Han | Author(s): Kai Li, Tianqing Chu, Minghong Bi, Helong Zhang, Yan Yu, Jianhua Shi, Xiaochun Zhang, Zhendong Chen, Cuicui Han, Tao Bai
- Abstract
Loading... -
+
P1.01-04 - A Phase II Trial of Weekly Nab-Paclitaxel in the Salvage Setting for Advanced Non-Small Cell Lung Cancer: Results of NICE Salvage Study
09:45 - 09:45 | Presenter: Yoshihito Kogure | Author(s): Takashi Niwa, Hiroshige Yoshioka, Hideo Saka, Akito Hata, Nobuyuki Katakami, Yuichi Ozawa, Norikazu Matsuo, Tomoaki Hoshino, Kazushige Wakuda, Hirotsugu Kenmotsu, Toshiaki Takahashi, Kaname Nosaki, Mitsuhiro Takenoyama, Manabu Tajima, Kazuhisa Takahashi, Masahiko Ando, Nobuyuki Yamamoto
- Abstract
Loading... -
+
P1.01-05 - Phase I Study of Inhaled 5-Azacytidine (5-Aza) in Patients (Pts) with Advanced Non-Small Cell Lung Cancer (NSCLC)
09:45 - 09:45 | Presenter: Haiying Cheng | Author(s): Ni Fan, Yiyu Zou, Chirag Shah, Balazs Halmos, Tushar D. Bhagat, Rasim Gucalp, Bilal Piperdi, Mimi Kim, Amit Verma, Simon Spivack, Roman Perez-Soler
- Abstract
Loading... -
+
P1.01-06 - Comparative Effectiveness of First Line (1L) Therapies for Advanced Non-Small Cell Lung Cancer (aNSCLC): A Systematic Literature Review (SLR)
09:45 - 09:45 | Presenter: Beata Korytowsky | Author(s): Sarah Goring, Tina Jun Jian Li, Aleksandra Gara, Nebibe Varol, Nadine Hertel, Paul Baas
- Abstract
Loading... -
+
P1.01-07 - Real World Data of Docetaxel Plus Nintedanib for Pretreated NSCLC Patients: 4 Yrs Update Compassionate Use Program Single Institution in Mexico
09:45 - 09:45 | Presenter: Saul Campos-Gomez | Author(s): Karen Campos-Gomez, Juan Jesús Valdéz-Andrade, Janeth Esquivel Gutierrez
- Abstract
Loading... -
+
P1.01-08 - Randomized Phase II Trial of CBDCA+nab-PTX vs CDDP+GEM in Patients with Chemo-Naïve Squamous Cell Lung Cancer: NJLCG1302
09:45 - 09:45 | Presenter: Toshiyuki Harada | Author(s): Yosuke Kawashima, Yuka Fujita, Taku Nakagawa, Kana Watanabe, Naoto Morikawa, Kei Takamura, Kenya Kanazawa, Kuda Tomoya, Kazuhiro Usui, Akira Inoue, Akimasa Sekine, Shunichi Sugawara
- Abstract
Loading... -
+
P1.01-09 - Randomized Trial Comparing Maintenance Pemetrexed with Observation Followed by Pemetrexed at Progression in Advanced NSCLC
09:45 - 09:45 | Presenter: Kristin Stokke | Author(s): Tarje O Halvorsen, Oystein Flotten, Sveinung Sorhaug, Tesfaye Madebo, Sunil Xavier Raj, Kristin Toftaker Killingberg, Sverre Fluge, Kjersti Hornslien, Bjorn Henning Gronberg
- Abstract
Loading... -
+
P1.01-10 - Impact of Anti-COPD Support Treatment in Advanced NSCLC Patients with COPD Undergoing Chemotherapy as First-Line Treatment
09:45 - 09:45 | Presenter: Fei Wang | Author(s): Xiaohong Xie, Xinqing Lin, Yinyin Qin, Zhanhong Xie, Jiexia Zhang, Ming Ouyang, Chengzhi Zhou
- Abstract
Loading... -
+
P1.01-100 - Effect of Osimertinib in Non-Small Cell Lung Cancer Patients with Brain Metastases After Progression Following Front-Line EGFR-TKI Therapy
09:45 - 09:45 | Presenter: Yun Fan | Author(s): Xiaoqing Yu
- Abstract
Loading... -
+
P1.01-101 - Efficacy of Immune Checkpoint Inhibition in RET Fusion Positive Non-Small Cell Lung Cancer Patients
09:45 - 09:45 | Presenter: Anthony N Sireci | Author(s): Deborah Morosini, Stephen Michael Rothenberg
- Abstract
Loading... -
+
P1.01-102 - Actionable Gene Aberration and the Response of Matched Therapy Among Patients with Non-Small-Cell Lung Carcinoma
09:45 - 09:45 | Presenter: Takaaki Mizuno | Author(s): Yutaka Fujiwara, Noboru Yamamoto, Kuniko Sunami, Takashi Kubo, Takashi Ichikawa, Ryo Morita, Jun Sato, Yasushi Goto, Hidehito Horinouchi, Shintaro Kanda, Shuji Murakami, Tatsuya Yoshida, Yuichiro Ohe, Takashi Kohno
- Abstract
Loading... -
+
P1.01-103 - Preliminary Results of Brigatinib in Japanese Patients (Pts) Who Previously Received Alectinib: Brigatinib-2001 Study
09:45 - 09:45 | Presenter: Shuji Murakami | Author(s): Takashi Seto, Miyako Satouchi, Makoto Nishio, Hidetoshi Hayashi, Yuichiro Ohe, Takayuki Asato, Pingkuan Zhang, Kazuhiko Nakagawa
- Abstract
Loading... -
+
P1.01-104 - Survivals in ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer Treated with First-Line Crizotinib
09:45 - 09:45 | Presenter: Yu-Er Gao | Author(s): Chang Lu, Hua-Jun Chen, Zhen Wang, Bin-Chao Wang, Xu-Chao Zhang, Chong-Rui Xu, Yi-Long Wu, Jin-Ji Yang
- Abstract
Loading... -
+
P1.01-105 - US Real-World Management of EGFR-Mutated Advanced NSCLC: Prescribing and Attrition Data from First-To-Second-Line Treatment
09:45 - 09:45 | Presenter: Karen L Reckamp | Author(s): Jorge Nieva, Aliki Taylor, Bharat Thakrar, Jennifer L Wong, Danielle Potter, Nicolaas A. Bakker, Wendy S Rubinstein, Ping Sun
- Abstract
Loading... -
+
P1.01-106 - Clinical Features and Tumor Immune Microenvironment Related to Acquired Resistance to EGFR-TKI in NSCLC Patients with EGFR Mutation
09:45 - 09:45 | Presenter: Pei Zhang | Author(s): Lingfang Tu, Rong Liu, Xuanli Xu, Zhang Bao, Panfeng Xu, Jie Wang, Hequan Li, Jianying Zhou, Yuehong Wang
- Abstract
Loading... -
+
P1.01-107 - KEYNOTE-495/KeyImPaCT: Phase 2 Biomarker-Directed Study of Pembrolizumab-Based Therapy for Non–Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Martin Gutierrez | Author(s): Matthew Hellmann, Matthew A. Gubens, Charu Aggarwal, Daniel SW Tan, Enriqueta Felip, Wei-Sen Lam, Joanne Wing Yan Chiu, Jong-Seok Lee, James Chih-Hsin Yang, Edward Garon, Andrea Basso, Hua Ma, Lawrence Fong, Alex Snyder, Jianda Yuan, Roy S. Herbst
- Abstract
Loading... -
+
P1.01-108 - PACIFIC-6: A Phase II Study of Durvalumab Following Sequential Chemoradiotherapy in Patients with Stage III, Unresectable NSCLC
09:45 - 09:45 | Presenter: Marina Chiara Garassino | Author(s): Corinne Faivre-Finn, Julien Mazieres, Martin Reck, Ugochi Emeribe, April Franks, Nataliya Trunova
- Abstract
Loading... -
+
P1.01-109 - Phase II Trial of Pemetrexed/Carboplatin/Bevacizumab +/- Atezolizumab in NSCLC Patients That Are EGFR Mutated or Never Smoked
09:45 - 09:45 | Presenter: J. Nicholas Bodor | Author(s): Jyoti D Patel, Eric A Ross, Samuel Litwin, Joseph Treat
- Abstract
Loading... -
+
P1.01-11 - Quality of Life in NSCLC Patients Treated with Docetaxel and Either Plinabulin or Pegfilgrastim for Prevention of Neutropenia
09:45 - 09:45 | Presenter: Douglas Blayney | Author(s): Dominic Mitchell, Yvette Lelorier, Lan Huang, Ramon W Mohanlal
- Abstract
Loading... -
+
P1.01-110 - Novel Regimens Versus Standard-of-Care in NSCLC: A Phase II, Randomized, Open-Label, Platform Trial Using a Master Protocol
09:45 - 09:45 | Presenter: David R Spigel | Author(s): Marina Chiara Garassino, Benjamin Besse, Adrian Sacher, Minal Barve, Sophie Cousin, Michael Schenker, Debra Rogan, Sapna Yadavilli, Andre Acusta, Ohad Amit, Ann Leighton-Swayze, Marc Ballas, Axel Hoos, Martin Reck, Sara Brett
- Abstract
Loading... -
+
P1.01-111 - ATEZO-BRAIN, A Single-Arm Phase II Study of Atezolizumab Combined with Chemotherapy in Stage IV NSCLC Patients with Untreated Brain Metastases
09:45 - 09:45 | Presenter: Ernest Nadal | Author(s): Rafael Lopez Castro, Oscar Juan, Gerardo Huidobro, Javier De Castro Carpeno, Ivana G. Sullivan, Joaquim Bosch-Barrera, Rosario Garcia Campelo, Anna Estival, Ana Blasco, Enriqueta Felip, Bartomeu Massuti, Maria Guirado, Delvys Rodriguez-Abreu, Manuel Dómine, Marta Simo, Valentin Navarro, Jordi Bruna
- Abstract
Loading... -
+
P1.01-112 - Phase 3, Randomized, Double-Blind Trial of First-Line Pembrolizumab With or Without Lenvatinib in Metastatic NSCLC: LEAP-007
09:45 - 09:45 | Presenter: Tarek Mekhail | Author(s): Sang-We Kim, Kaoru Kubota, Mariana González Del Riego, Larry Wu, Ayman Samkari, Tamer M. Fouad, James Chih-Hsin Yang
- Abstract
Loading... -
+
P1.01-113 - Phase 1b Trial of Cabozantinib or Cabozantinib Plus Atezolizumab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
09:45 - 09:45 | Presenter: Farah Louise Lim | Author(s): Santiago Ponce, Shiven B. Patel, Carla Van Herpen, Carla Kurkjian, Yanyan Lou, Yingjie Liu, Giridharan Ramsingh, Sumanta Pal, Joel W Neal
- Abstract
Loading... -
+
P1.01-114 - A Phase 2 Study of MLN4924 (Pevonedistat) in Combination with Carboplatin and Paclitaxel in Advanced NSCLC Previously Treated with Immunotherapy
09:45 - 09:45 | Presenter: Ticiana A. Leal | Author(s): Joshua M. Lang, Jennifer Schehr, Kasey Schneider, Deric Wheeler, Jyoti Malhotra, Erin M. Bertino, Jens Eickhoff, Anne M Traynor
- Abstract
Loading... -
+
P1.01-115 - Long-Term Effects of Concurrent Chemoradiotherapy on Quality of Life in Locally Advanced Non-Small Cell Lung Cancer Patients
09:45 - 09:45 | Presenter: Evalien Veldhuijzen | Author(s): Iris Walraven, Joachim G.J.V. Aerts, F Koppe, E. Dieleman, P. Van De Vaart, Michel Van Den Heuvel, José Belderbos
- Abstract
Loading... -
+
P1.01-116 - Early Immune-Related Adverse Events Under PD-1/PD-L1 Inhibitors Predict Better Progression-Free Survival in NSCLC
09:45 - 09:45 | Presenter: Maxime Boussageon | Author(s): Sandra Ortiz-Cuaran, Sylvie Chabaud, David Pérol, Virginie Avrillon, Bénédicte Mastroianni, Jérôme Fayette, Francois Ghiringhelli, Eve-Marie Neidhardt, Aurélie Swalduz, Valérie Paulus, Coureche Guillaume Kaderbhai, Jean-David Fumet, Pierre Saintigny, Maurice Perol
- Abstract
Loading... -
+
P1.01-117 - Pulmonary Function Monitoring in Patients with Oligometastatic NSCLC Who Receive Stereotactic Body Radiation Therapy
09:45 - 09:45 | Presenter: Marisol Arroyo-Hernandez | Author(s): Monika Blake-Cerda, Laura Gochicoa-Rangel, Sergio Monraz-Pérez, María Fernanda Cuevas Góngora, Dafne Valle Bautista, Pablo Alan Barragán Castillo, Federico Maldonado Magos, Oscar Rodríguez, Diana Flores, Oscar Gerardo Arrieta
- Abstract
Loading... -
+
P1.01-118 - Overall Survival in Pts with EGFRm+ NSCLC Receiving Sequential Afatinib and Osimertinib: Updated Analysis of the GioTag Study
09:45 - 09:45 | Presenter: Maximilian J. Hochmair | Author(s): Alessandro Morabito, Desiree Hao, Cheng-Ta Yang, Ross Soo, James Chih-Hsin Yang, Rasim Gucalp, Balazs Halmos, Lara Wang, Angela Märten, Tanja Cufer
- Abstract
Loading... -
+
P1.01-119 - Modified Lung Immune Prognostic Index (mLIPI) as a Predictive Tool of Nivolumab Outcomes in Advanced NSCLC Patients
09:45 - 09:45 | Presenter: Rebecca Jane Moor | Author(s): Kate Roberts, Rob Mason, Rahul Ladwa, Zarnie Lwin, Brett GM Hughes, Kenneth John O’Byrne
- Abstract
Loading... -
+
P1.01-12 - Trends in the National Cancer Institute (NCI) Sponsored Lung Cancer Clinical Trials Pre and Post NCI’s National Clinical Trials Network (NCTN)
09:45 - 09:45 | Presenter: Shakun Malik | Author(s): Grace Mishkin, Andrea Denicoff, Jinxiu Zhao, Edward Korn, Margaret Mooney
- Abstract
Loading... -
+
P1.01-120 - Immune Checkpoint Inhibitors Versus Second Line Chemotherapy for Patients with Lung Cancer Refractory to First Line Chemotherapy
09:45 - 09:45 | Presenter: Corentin Lefebvre | Author(s): Elodie Martin, Lizza Hendriks, Remi Veillon, Thomas Filleron, Florent Puisset, Laura Mezquita, Roberto Ferrara, Mireille Sabatier, Benjamin Besse, Anne Marie Clasina Dingemans, Julien Mazieres
- Abstract
Loading... -
+
P1.01-121 - Superior Outcomes of 1st Line EGFR TKI in Next-Generation Sequencing Identified Uncommon EGFR Exon 19delins Mutation Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Yongchang Zhang | Author(s): Nong Yang, Tao Jiang, Caicun Zhou
- Abstract
Loading... -
+
P1.01-122 - A Clinical Utility Study of Plasma DNA Next Generation Sequencing Guided Treatment of Uncommon Drivers in Advanced Non-Small-Cell Lung Cancers
09:45 - 09:45 | Presenter: Hai-yan Tu | Author(s): Chong-Rui Xu, Candace Tong-Li, Michael Offin, Pedram Razavi, Emily Schapira, Azadeh Namakydoust, Adrian Lee, Nick Pavlakis, Stephen Clarke, Connie I Diakos, David Chan, Makenzie L Myers, Alex Makhnin, Harsh Jain, Andres Martinez, Zishan Iqbal, Ariana Adamski, Henry Li, Jennifer Hernandez, Sara Watford, Ali Hosseini, Tristan Shaffer, Lee Lim, Mark Li, Alexander Drilon, Marc Ladanyi, Maria E. Arcila, Valerie W. Rusch, David R Jones, Charles M Rudin, Andreas Rimner, James M Isbell, Bob T Li
- Abstract
Loading... -
+
P1.01-123 - Recent Clinical Outcomes of Upfront Surgery Followed by Adjuvant Therapy for Resectable Pathological N2 Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Jae Kwang Yun | Author(s): Yooyoung Chong, Yong Ho Jeong, Han Pil Lee, Jin San Bok, Geun Dong Lee, Hyeong Ryul Kim, Yong-Hee Kim, Dong Kwan Kim, Seung-Il Park, Sehoon Choi
- Abstract
Loading... -
+
P1.01-124 - Health-Related Quality of Life (HRQoL) Data in a Phase 3 Study of First-Line Brigatinib vs Crizotinib in NSCLC (ALTA-1L)
09:45 - 09:45 | Presenter: Rosario Garcia Campelo | Author(s): Huamao Mark Lin, Maurice Perol, Mohammad Jahanzeb, Sanjay Popat, Yanyan Zhu, Pingkuan Zhang, D. Ross Camidge
- Abstract
Loading... -
+
P1.01-125 - Uniportal Versus Multiportal Thoracoscopic Lobectomy with Systematic Mediastinal Lymphadenectomy for N2(+) Stage III NSCLC
09:45 - 09:45 | Presenter: Youjun Deng | Author(s): Jia-qing Wang, Zhe Wang, Zheng Wang, Ju-wei Mu, Guang-suo Wang
- Abstract
Loading... -
+
P1.01-126 - The Co-Occurring Genomic Landscape of ERBB2 Exon 20 Insertion in Non-Small Cell Lung Cancer (NSCLC) and the Potential Indicator of Response to Afatinib
09:45 - 09:45 | Presenter: Bo Yuan | Author(s): Jun Zhao, Chengzhi Zhou, Xiumei Wang, Bo Zhu, Minglei Zhuo, Cuihua Yi, Hua Zhang, Xilin Dong, Jiemei Feng, Yunpeng Yang, Wangyan Zhou, Zhengtang Chen, Sheng Yang, Yanjun Zhang, Xinghao Ai, Kehe Chen, Xuefan Cui, Difa Liu, Wei Wu, Chunmei Shi, Lian-peng Chang, Jin Li, Rongrong Chen, Shuanying Yang
- Abstract
Loading... -
+
P1.01-127 - Antitumor Activity of the Oral EGFR/HER2 Inhibitor TAK-788 in NSCLC with EGFR Exon 20 Insertions
09:45 - 09:45 | Presenter: Gregory J Riely | Author(s): Joel W Neal, D. Ross Camidge, Alexander Spira, Zosia Piotrowska, Leora Horn, Daniel B Costa, Anne Tsao, Jyoti D Patel, Shirish Gadgeel, Lyudmila Bazhenova, Viola W. Zhu, HOWARD WEST, Sylvie Vincent, Jian Zhu, Shu Jin, Steven Zhang, Shuanglian Li, Pasi A Jänne
- Abstract
Loading... -
+
P1.01-128 - Choice of Postoperative Radiotherapy for Resected IIIA-N2 Non-Small Cell Lung Cancer: Impact of Log Odds of Positive Lymph Nodes
09:45 - 09:45 | Presenter: Yang Wo | Author(s): Hongxia Yang, Yuanyong Wang, Tong Lu, Wenxing Du, Wenjie Jiao
- Abstract
Loading... -
+
P1.01-129 - Preclinical Genetic Evaluation of Alternating ALK TKI Therapy Versus Continuous Dosing in ALK NSCLC to Inform the ALKternate Clinical Trial
09:45 - 09:45 | Presenter: Malinda Itchins | Author(s): Amanda L Hudson, Sarah A Hayes, Rozelle Harvie, Grace Heng Wei, Michael Buckland, Stephen Clarke, Viive M Howell, Nick Pavlakis
- Abstract
Loading... -
+
P1.01-13 - Efficacy and Safety of Concurrent Anti-Tuberculosis Treatment and Chemotherapy in Lung Cancer Patients with Co-Existent Tuberculosis
09:45 - 09:45 | Presenter: Shan Su | Author(s): Meifeng Ye, Wenchang Cen, Xianlan Zhang, Zhihao Huang, Jianjun Zou, Yunyun Zeng, Yanbin Zhang
- Abstract
Loading... -
+
P1.01-130 - Clinical Experience with Nintedanib in Previously Treated Non-Small Cell Lung Cancer in Spain: A Retrospective Multicenter Study
09:45 - 09:45 | Presenter: Laura Gutiérrez Sainz | Author(s): Patricia Cruz, Carlos Aguado, Mónica Antoñanzas, Xavier Mielgo, Luis Cabezón, Luis Enrique Chara, Elia Martinez Moreno, Yolanda Lage Alfranca, Alejandro Velastegui, Miguel Sotelo, Ana Garcia Rueda, María Eugenia Olmedo, Sergio Martínez Recio, Javier De Castro Carpeno
- Abstract
Loading... -
+
P1.01-131 - The Comparison Between Non-Intubated and Intubated Anesthesia Video-Assisted Thoracoscopic Surgery: A Meta-Analysis
09:45 - 09:45 | Presenter: Guanping Qiu
- Abstract
Loading... -
+
P1.01-132 - Clinicopathological and Genomic Comparisons Between Different Histologic Components in Combined Small Cell and Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Mong-Wei Lin | Author(s): Kang-Yi Su, Min-Shu Hsieh, Sung-Liang Yu, Jin-Shing Chen
- Abstract
Loading... -
+
P1.01-133 - Randomized Open-Label Study of Bintrafusp Alfa (M7824) vs Pembrolizumab in Patients with PD-L1 Expressing Advanced 1L NSCLC
09:45 - 09:45 | Presenter: Myung-Ju Ahn | Author(s): Fabrice Barlesi, Enriqueta Felip, Edward Garon, Claudio Martin, Tony Mok, Everett E. Vokes, Laureen S. Ojalvo, Andre Koenig, Isabelle Dussault, Luis Paz-Ares
- Abstract
Loading... -
+
P1.01-134 - SAVANNAH: Phase II Trial of Osimertinib + Savolitinib in EGFR-Mutant, MET-Driven Advanced NSCLC, Following Prior Osimertinib
09:45 - 09:45 | Presenter: Myung-Ju Ahn | Author(s): Mireille Cantarini, Paul Frewer, George Hawkins, Jane Peters, Paul Howarth, Ghada F Ahmed, Tarjinder Sahota, Ryan Hartmaier, Xiaocheng Li-Sucholeiki, Geoffrey R Oxnard
- Abstract
Loading... -
+
P1.01-135 - Salvage Chemotherapy After Immunotherapy Failure in Non-Small-Cell Lung Cancer Patients
09:45 - 09:45 | Presenter: Giuseppe Lo Russo | Author(s): Giovanni Randon, Giulia Galli, Alessandro De Toma, Filippo Pagani, Benedetta Trevisan, Diego Signorelli, Claudia Proto, Arsela Prelaj, Roberto Ferrara, Monica Ganzinelli, Linda Pallavicini, Rosa Di Mauro, Nicoletta Zilembo, Filippo Guglielmo Maria De Braud, Marina Chiara Garassino
- Abstract
Loading... -
+
P1.01-136 - Uncommon EGFR Mutations in Non-Small Cell Lung Cancer: A Systematic Literature Review of Prevalence and Clinical Outcomes
09:45 - 09:45 | Presenter: Tom John | Author(s): Aliki Taylor, Huifen Wang, Diana Cripps, Christian Eichinger, Caroline Freeman, Myung-Ju Ahn
- Abstract
Loading... -
+
P1.01-137 - KNSTRN Promotes Non-Small Cell Lung Cancer Progress and Attenuates Radiosensitivity via Activating EGFR-ERK1/2-E2F1 Pathway
09:45 - 09:45 | Presenter: Conghua Xie | Author(s): Shijing Ma
- Abstract
Loading... -
+
P1.01-14 - The Impact of Systemic Treatment on Brain Metastasis in Patients with Non-Small-Cell Lung Cancer: A Nationwide Population-Based Cohort Study
09:45 - 09:45 | Presenter: Yoon Ho Ko | Author(s): Ji Hyung Hong, Der Sheng Sun, Hye Sung Won, Jung Soo Lee, Hyun Woo Lee
- Abstract
Loading... -
+
P1.01-15 - Multicenter, Single-Arm Phase II Study of Nab-Paclitaxel/Carboplatin in Untreated PS2 Patients with Advanced NSCLC: TORG1426
09:45 - 09:45 | Presenter: Katsuhiko Naoki | Author(s): Yasuko Ichikawa, Akihiro Bessho, Shinobu Hosokawa, Tsuneo Shimokawa, Makiko Yomota, Yukio Hosomi, Sakiko Otani, Yoshiro Nakahara, Shunichiro Iwasawa, Takaaki Tokito, Nobuhiko Seki, Hiroaki Okamoto
- Abstract
Loading... -
+
P1.01-16 - Evolution of Systemic Therapy Uptake in NSCLC Over Time: The Impact of New Therapies
09:45 - 09:45 | Presenter: Paul Wheatley-Price | Author(s): Katie Laurie, Mathieu Foster McKinnon
- Abstract
Loading... -
+
P1.01-17 - Changes in Pulmonary Function During Platinum-Doublet Chemotherapy for Lung Cancer
09:45 - 09:45 | Presenter: Jeremias Götschke | Author(s): Camilla Von Wachter, Laura Sellmer, Pontus Mertsch, Diego Kauffmann-Guerrero, Zulfiya Syunyaeva, Amanda Tufman
- Abstract
Loading... -
+
P1.01-18 - Integrated Genomic and DNA Methylation Analyses of Non-Small Cell Lung Cancer Patients with Brain Metastases
09:45 - 09:45 | Presenter: Yun Fan | Author(s): Yanjun Xu, Zhiyu Huang, kaiyan Chen, Han Han-Zhang, Junyi Ye, Hongyang Lu, jing Qin, fajun Xie, na Han, lei Gong, xiaoling Xu
- Abstract
Loading... -
+
P1.01-19 - Predictive and Prognostic Values of ctDNA Clearance in Osimertinib Treated Advanced Non-Small Cell Lung Cancer Cohort
09:45 - 09:45 | Presenter: Yong Song | Author(s): Shenglin Ma, Meiqi Shi, Xingxiang Xu, Xueqin Chen, Yong Wang, Zhenhua Yang, Tengfei Zhang, Min Li, Haiyan Li, Lu Zhang, Xinru Mao
- Abstract
Loading... -
+
P1.01-20 - The Association Between BRAF Mutation Class and Clinical Features in BRAF-Mutant Chinese Non-Small Cell Lung Cancer Patients
09:45 - 09:45 | Presenter: Quan Lin | Author(s): Hong Zhu, Yuping Li, Haoran Zhang, Huaxin Ding, Jun Qian, Han Han-Zhang, Jing Lin, Jianxing Xiang
- Abstract
Loading... -
+
P1.01-21 - Sputum Can Serve as an Alternative Source for Liquid Biopsy in Patients with Lung Cancer
09:45 - 09:45 | Presenter: Ling Qin | Author(s): Ting Guo, Huaping Yang, Qihua Gu, Liming Cao, Pengbo Deng, Bing Li, Zhiqiu Chen, Chengping Hu
- Abstract
Loading... -
+
P1.01-22 - Investigation of Acquired Resistance for EGFR-TKI Plus Bevacizumab as 1st Line Treatment in Patients with EGFR Sensitive Mutant NSCLC
09:45 - 09:45 | Presenter: Yongchang Zhang | Author(s): Liang Zeng, Nong Yang, Tao Jiang, Caicun Zhou
- Abstract
Loading... -
+
P1.01-23 - Retrospective Analysis of Real-World Clinico-Genomic Data for Clinical Impact of Genomic Profiling of ctDNA in NSCLC
09:45 - 09:45 | Presenter: Russell Madison | Author(s): Alexa Betzig Schrock, Jeffrey Gregg, Ken Carson, Emily Castellanos, Gaurav Singal, Vincent A Miller, Siraj M Ali, Brian Alexander, Jon Hua Chung
- Abstract
Loading... -
+
P1.01-24 - Preclinical Proteomic Evaluation of Alternating ALK TKI Therapy Versus Continuous Dosing in ALK NSCLC to Inform the ALKternate Clinical Trial
09:45 - 09:45 | Presenter: Malinda Itchins | Author(s): Amanda L Hudson, Rozelle Harvie, Thiri Zaw, Matthew McKay, Stephen Clarke, Viive M Howell, Nick Pavlakis, Sarah A Hayes
- Abstract
Loading... -
+
P1.01-25 - Real-World Outcomes of Advanced NSCLC Patients with Common and Uncommon/Complex EGFR Mutation Profiles
09:45 - 09:45 | Presenter: Gregory J Riely | Author(s): Christine M Lovly, Carlo G M Messina, Stefanie Bienert, Kimberly Alexander, William Pao, Kelly M Magee, Shrujal S Baxi, Robert C. Doebele
- Abstract
Loading... -
+
P1.01-26 - TP53 Mutations in EGFR mt+ NSCLC IV: Strong Independent Predictive Factor for ORR, PFS and OS Irrespective of T790M
09:45 - 09:45 | Presenter: Julia Roeper | Author(s): Markus Falk, Fabian Otto-Sobotka, Frank Griesinger
- Abstract
Loading... -
+
P1.01-27 - Serial Circulating Tumor DNA (ctDNA) Analysis of Blood and Saliva Predicts Osimertinib Response and Resistance in EGFR-Mutant NSCLC
09:45 - 09:45 | Presenter: Chul Kim | Author(s): Liqiang Xi, Constance M Cultraro, Fang Wei, Jordan Cheng, Ahmad Shafiei, Trinh Hoc-Tran Pham, Nitin Roper, Elizabeth Akoth, Charles Strom, Michael Tu, Wei Liao, David Chia, Clive Morris, Arun Rajan, Mohammadhadi Bagheri, Gregory Jones, David T.W. Wong, Mark Raffeld, Udayan Guha
- Abstract
Loading... -
+
P1.01-28 - Mutational Heterogeneity Between Primary Pulmonary Cancer Lesions and Matched Brain Metastases
09:45 - 09:45 | Presenter: Linlin link Li | Author(s): Yu Chen, Hong-Xia Tian, De-Xiang Zhou, Dong Zhou, Xiao-Feng Lin, Kai Yin, Hui-Bo Feng, Wei-Bang Guo, Zhi Xie, Wen-Qing Yan, Zhi-Yi Lv, Dan-Xia Lu, Xue-Ning Yang, Yi-Long Wu, Xu-Chao Zhang
- Abstract
Loading... -
+
P1.01-29 - MLPH Promotes Epithelial–Mesenchymal Transition and Brain Metastasis via Cdc42/PAK1 Signaling in Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Xiaorong Dong | Author(s): Chunhua Wei, ling Peng, fan Tong
- Abstract
Loading... -
+
P1.01-30 - Non-Small Cell Lung Cancer (NSCLC) Next Generation Sequencing (NGS): Integrating Genomic Sequencing into a Publicly Funded Health Care Model
09:45 - 09:45 | Presenter: Natasha B Leighl | Author(s): Kirstin Perdrizet, Tracy Stockley, Jennifer H Law, Muqdas Shabir, Tong Zhang, Lisa Le, Anthea Lau, Ming Sound Tsao, Suzanne Kamel-Reid, Prodipto Pal, Michael Cabanero, Joerg Schwock, Hyangmi Ko, Geoffrey Liu, Penelope A Bradbury, Adrian G Sacher, Frances Shepherd
- Abstract
Loading... -
+
P1.01-31 - Evaluating Engineered Heme-Sequestering Peptides for Treating Non-Small Cell Lung Cancer Orthotopic Tumor Model Using Multi-Modality Imaging
09:45 - 09:45 | Presenter: Li Liu | Author(s): Shigen Zhong, Jingyu Chen, James Campbell, Jeni Gerberich, Guiyang Hao, Li Zhang
- Abstract
Loading... -
+
P1.01-32 - Bronchoalveolar Lavage as an Alternative to Rebiopsy for Detection of T790M Mutation in NSCLC Patients with Acquired Resistance to EGFR-TKIs
09:45 - 09:45 | Presenter: Heejoung Kim | Author(s): Jae Young Hur, In Ae Kim, Seungeun Lee, Wan Seop Kim, Kye Young Lee
- Abstract
Loading... -
+
P1.01-33 - Genetic Variants in FIG4 and IGF1R in the Endosome-Related Genes Are Associated with Non-Small Cell Lung Cancer Survival
09:45 - 09:45 | Presenter: Qiming Wang | Author(s): Sen Yang, Qingyi Wei, David C Christiani
- Abstract
Loading... -
+
P1.01-34 - Early Assessment of Therapy Response in Non-Small Cell Lung Cancer (NSCLC) via Longitudinal ctDNA Analysis
09:45 - 09:45 | Presenter: Stephanie Yaung | Author(s): Xiaoju Max Ma, Christine Ju, Corinna Woestmann, Liu Xi, Bernd Hinzmann, Michael Thomas, Claus-Peter Heussel, Felix Lasitschka, Michael Meister, Marc Andre Schneider, Felix Herth, Thomas Muley, Birgit Wehnl, John F. Palma
- Abstract
Loading... -
+
P1.01-35 - Real World Characterization of Advanced Non-Small Cell Lung Cancer in Never Smokers
09:45 - 09:45 | Presenter: Katie Kerrigan | Author(s): Benjamin Haaland, Blythe Adamson, Shiven B. Patel, Wallace Akerley
- Abstract
Loading... -
+
P1.01-36 - Clinical Potential of Tissue Tumor Mutational Burden (tTMB) and Blood TMB (bTMB) as a Biomarker in Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Jianying Zhou | Author(s): Jianya Zhou, Xi Chen, Yanping Zhu, Liangjie Fang, Zhang Bao, Rong Liu, He Cao, Wenjia Sun, Tengfei Zhang, Jing Lin, Bing Yu
- Abstract
Loading... -
+
P1.01-37 - Radiotherapy Changed the Subclonal Composition of Brain Metastasis from Non Small Cell Lung Cancer: NGS-Based Analysis of Cerebrospinal Fluid
09:45 - 09:45 | Presenter: Xiaoxia Zhu | Author(s): Lijuan Wang, Xiaotong Duan
- Abstract
Loading... -
+
P1.01-38 - Clinical Significance According to EGFR Mutation Subtypes in Lung Adenocarcinoma: Korean Multicenter Experience
09:45 - 09:45 | Presenter: Jung Hyun Chang | Author(s): Hee Yeung Yoon, Dojin Kim, Jeong-Seon Ryu, Sung Yong Lee, Yun Su Sim, Juwhan Choi
- Abstract
Loading... -
+
P1.01-39 - Is There an Association Between Intracranial Progression and Overall Survival or Neurologic Death in Patients with EGFR Positive NSCLC?
09:45 - 09:45 | Presenter: Mark Doherty | Author(s): Matthew Ramotar, David Shultz
- Abstract
Loading... -
+
P1.01-40 - EGFR ctDNA Detection: The Impact of Site of Progression and Burden of Progressive Disease
09:45 - 09:45 | Presenter: Alexandra Pender | Author(s): Curtis Hughesman, Elaine Law, Amadea Kristanti, Kelly McNeil, Tracy Tucker, Ian Bosdet, Sean Young, Janessa J. Laskin, Aly Karsan, Stephen Yip, Cheryl Ho
- Abstract
Loading... -
+
P1.01-41 - Involvement of the JNK Pathway in Bruceine D-Induced Apoptosis in Human Non-Small Cell Lung Cancer Cells
09:45 - 09:45 | Presenter: Bi qin Tan | Author(s): fei Wang, yu yu Huang, li hua Lan, bo Zhang, neng ming Lin
- Abstract
Loading... -
+
P1.01-42 - Whole-Exome Sequencing Identifies Novel Somatic Mutations Associated with Prognosis in Lung Cancer Metastatic to the Brain
09:45 - 09:45 | Presenter: Chunxia Su | Author(s): xuefei Li, Chao Zhao, Jing Zhao
- Abstract
Loading... -
+
P1.01-43 - Programmed-Death Ligand 1 Spectrum in a Large Cohort of Genetically Characterized Non-Small Cell Lung Cancer Patients
09:45 - 09:45 | Presenter: Elba Marin | Author(s): Cristina Teixido, Elena Carmona, Ainara Arcocha, Carlos Cabrera, Daniel Martinez, Pedro Jares, Nuria Viñolas, Aleix Prat, Noemi Reguart
- Abstract
Loading... -
+
P1.01-44 - The Role of Microbiota on the Development of Non-Small-Cell Lung Cancer
09:45 - 09:45 | Presenter: Xiaorong Dong | Author(s): Hui Lu, Jiaojiao Wang, Huanhuan Li, Ying Wang, fan Tong, Gang Wu
- Abstract
Loading... -
+
P1.01-45 - A NGS-Based ctDNA Test to Monitor Disease Progression and Treatment Response in Advanced Stage Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Jin Jen | Author(s): Jang Sung Jang, Jin Zhang, Angelina Tang, Karlyn Pierson, Amy J Schrandt,, Hao Xie, Ping Yang, sumithra J Mandreka, Aaron S. Mansfield
- Abstract
Loading... -
+
P1.01-46 - Response Assessment Using Plasma Cell-Free DNA (cfDNA) – When Is the Optimal Time to Assess Response?
09:45 - 09:45 | Presenter: Michael L Cheng | Author(s): Christie J Lau, Marina S. D. Milan, Julianna G Supplee, Jonathan W. Riess, Penelope A Bradbury, Cloud P Paweletz, Geoffrey R Oxnard
- Abstract
Loading... -
+
P1.01-47 - Prospective Study for Usefulness of Plasma DNA on Prediction of Third Generation EGFR Tyrosine Kinase Inhibitors (S-PLAT Study)
09:45 - 09:45 | Presenter: Chiho Nakashima | Author(s): Hironori Yoshida, Naohisa Matsumoto, Kentarou Iwanaga, Noriyuki Ebi, Akihiro Nishiyama, Kazuhiro Yatera, Shoichi Kuyama, Minoru Fukuda, Sunao Ushijima, Hitomi Umeguchi, Daijiro Harada, Koichi Kashiwabara, Takayuki Suetsugu, Nobukazu Fujimoto, Fumihiro Tanaka, Hidetaka Uramoto, Chiharu Yoshii, Katsumi Nakatomi, Kaname Nosaki, Yasuko Ichikawa, Keisuke Aoe, Kouji Inoue, Koichi Takayama, Masato Kato, Naoko Sueoka-Aragane
- Abstract
Loading... -
+
P1.01-48 - EGFR Testing in England – Real World Evidence from the National Lung Cancer Audit (NLCA) Spotlight on Molecular Testing
09:45 - 09:45 | Presenter: Neal Navani | Author(s): Judith Tweedie, Aamir Khakwani, Richard Hubbard, Natasha Wood, Susan Harden, Paul Beckett
- Abstract
Loading... -
+
P1.01-49 - Serial Changes in Whole-Genome Cell-Free DNA (cfDNA) to Identify Disease Progression Prior to Imaging in Advanced NSCLC
09:45 - 09:45 | Presenter: Young Kwang Chae | Author(s): Andrew A. Davis, Wade T Iams, David Chan, Michael S Oh, Robert W Lentz, Neil Peterman, Alex Robertson, Abhik Shah, Rohith Srivas, Nicole Lambert, Timothy Wilson, Ayse Tezcan, John C. Spinosa, Haluk Tezcan, Nisha Anjali Mohindra, Victoria Meucci Villaflor
- Abstract
Loading... -
+
P1.01-50 - Impact of Concomitant HER2 Alterations in Mediating Clinical Outcomes of EGFR-Mutant Patients to Different Generation of EGFR-TKIs
09:45 - 09:45 | Presenter: Ying Cheng | Author(s): Ying Liu, Lixia Ma, Jing Zhu, Changliang Yang, Liang Zhang, Tingting Zhang, Hui Jiang, Yang Zhang, Yanrong Wang, Jie Hao, Lu Zhang, Hanhan Zhang, Tengfei Zhang, Jing Lin, Liming Shi
- Abstract
Loading... -
+
P1.01-51 - Micropapillary Predominant and Pathologic Stage Were Risk Factors for Postoperative Brain Metastasis in Lung Adenocarcinoma
09:45 - 09:45 | Presenter: Takao Shigenobu | Author(s): Yohei Masugi, Ryutaro Hanawa, Atsushi Tajima, Yusuke Takahashi
- Abstract
Loading... -
+
P1.01-52 - Cell-Free Tumor DNA (ctDNA) Utility in Detection of Original Sensitizing and Resistant EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC)
09:45 - 09:45 | Presenter: Jason Scott Agulnik | Author(s): Goulnar Kasymjanova, David Small, Carmela Pepe, Lama Sakr, George Chong, Hangjun Wang, Andreas Papadakis, Alan Spatz, Victor Cohen
- Abstract
Loading... -
+
P1.01-53 - Clinical Utility of Two Different Plasma-Based EGFR Mutation Tests in Patients with Advanced Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Yun-Gyoo Lee | Author(s): Kyunghoon Lee, Sangeun Lim, Min-Jung Kwon, Hyosoon Park, Hee-Yeon Woo
- Abstract
Loading... -
+
P1.01-54 - Somatic Genome Alterations in Lung Cancer Patients Diagnosed with Li Fraumeni Syndrome
09:45 - 09:45 | Presenter: Maria Jove | Author(s): Teresa Moran, Alex Teule, Mireia Menendez, Mireia Gausachs, Noelia Vilariño, Ramon Palmero Sánchez, Beatriz Cirauqui, Anna Estival, Enric Carcereny, Marta Domenech, Matilde Navarro, Joaquim Bosch-Barrera, Claudia Fina, Angel Izquierdo, Jose Carlos Ruffinelli, Mar Varela, Carles Mesia, Alejandro Hernandez, Sara Gonzalez, Contxi Lazaro, Joan Brunet, Ernest Nadal
- Abstract
Loading... -
+
P1.01-55 - Updated Analysis of Outcomes by Histology vs Cytology PD-L1 22C3 Antibody Testing in Advanced Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Arani Sathiyapalan | Author(s): Ying Wang, Rosalyn Anne Juergens, Martin Butcher, Asghar Naqvi, Jean-Claude Cutz
- Abstract
Loading... -
+
P1.01-56 - Increased ROS1 and RET Transcripts in Fusion-Negative NSCLC Patients
09:45 - 09:45 | Presenter: Noemi Reguart | Author(s): Cristina Aguado, Cristina Teixido, Ana Gimenez-Capitan, Elba Marin, Ana Peréz-Rosado, Carlos Cabrera, Ruth Román, Irene Moya, Santiago Viteri, Rafael Rosell, Miguel Angel Molina-Vila
- Abstract
Loading... -
+
P1.01-57 - Association of Initial PD-L1 Expression with T790M-Acquired Resistance in Advanced EGFR-Mutant Lung Adenocarcinoma Patients
09:45 - 09:45 | Presenter: Kazumi Nishino | Author(s): Aki Kubota, Kei Kunimasa, Madoka Kimura, Takako Inoue, Motohiro Tamiya, Hanako Kuhara, Toru Kumagai
- Abstract
Loading... -
+
P1.01-58 - Comprehensive Serial Biomaterial Acquisition in Advanced NSCLC: Feasibility, Challenges and Perspectives
09:45 - 09:45 | Presenter: Marc Andre Schneider | Author(s): Sabine Wessels, Petros Christopoulos, Thomas Muley, Michael Meister, Ingrid Heinzmann-Groth, Arne Warth, Esther Herpel, Albrecht Stenzinger, Simone Hummler, Ursula Klingmueller, Jonas Kuon, Claus-Peter Heussel, Ralf Eberhardt, Felix Herth, Hauke Winter, Helge Bischoff, Martin Reck, Rudolf Maria Huber, Michael Thomas
- Abstract
Loading... -
+
P1.01-59 - Expanding Access to Large-Scale Genomic Mutational Analyses for Patients with Advanced NSCLC in Italy
09:45 - 09:45 | Presenter: Vanesa Gregorc | Author(s): Chiara Lazzari, Alessandro Guida, Gabriele Bucci, Paolo Graziano, Maria Giulia Cangi, Gianmaria Frigè, Antonio Rossi, Arnaud Ceol, Davide Sardina, Michele Milella, Matteo Pallocca, Paolo Vigneri, Laura Fancello, Simonetta Buglioni, Gianmarco Motta, Tommaso Biagini, Erika Rijavec, Silvia Bonfiglio, Angelo Delmonte, Luca Toschi, Giuseppe Banna, Domenico Galetta, Alessandra Bearz, Alfredo Tartarone, Francesco Verderame, Mariagrazia Daidone, Maurizio Fanciulli, Gennaro Ciliberto, Pier Giuseppe Pelicci, Ruggero De Maria, Luca Mazzarella
- Abstract
Loading... -
+
P1.01-60 - Prognostic Impact of PD-L1 Expression on EGFR Tyrosine Kinase Inhibition in Lung Adenocarcinoma
09:45 - 09:45 | Presenter: Minsu Kang | Author(s): Se Hyun Kim, Sock Won Yoon, Koung Jin Suh, Yu Jung Kim, Chan-Young Ock, Miso Kim, Bhumsuk Keam, Tae Min Kim, Dae Seog Heo, Jong-Seok Lee
- Abstract
Loading... -
+
P1.01-61 - A Phase II Umbrella Study of Camrelizumab in Different PD-L1 Expression Cohorts in Pre-Treated Advanced/Metastatic Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Yi-Long Wu | Author(s): Cheng Huang, Yun Fan, Jifeng Feng, Hong-ming Pan, Liyan Jiang, Jin-Ji Yang, Xing-Ya Li, Xiao-Qing Liu, Jiang-Ping Xiong, Yan-Qiu Zhao, Ying Cheng, rui Ma, Jie Wang, Yi-Na Wang, Yan-Hui Liu, Dong-Mei Lin, Wei Shi, Xiang Lin
- Abstract
Loading... -
+
P1.01-62 - Association of Baseline Pulmonary Fibrosis with the Outcome of PD-1 Inhibitor in Patients with Advanced Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Shiqi Mao | Author(s): Yiwei Liu, Fei Zhou, Anwen Xiong, Bin Chen, Guanghui Gao, Jia Yu, fengying Wu, Yayi He, Xiaoxia Chen, Chunxia Su, Shengxiang Ren, Caicun Zhou
- Abstract
Loading... -
+
P1.01-63 - Impact of Prior Radiation Pneumonitis on Incidence of Immunotherapy Related Pneumonitis
09:45 - 09:45 | Presenter: Charu Aggarwal | Author(s): Melanie Wain Kier, Melina E Marmarelis, Christiana Davis, Varsha Jain, Abigail Berman, Joshua M Bauml, Aditi Singh, Christine Ciunci, Corey Jay Langer, Roger B Cohen
- Abstract
Loading... -
+
P1.01-64 - Predictive Value of K-Ras Subset Mutations and PD-L1 in Pulmonary Sarcomatoid Carcinoma (PSC)
09:45 - 09:45 | Presenter: Nagla Abdel Karim | Author(s): ihab Eldessouki, Rammey Hassan, Patrick C. Ma
- Abstract
Loading... -
+
P1.01-65 - Immune Gene Expression, Bayesian Network and Genetic Mutation Analysis in Advanced NSCLC Patients Treated with Immunotherapy
09:45 - 09:45 | Presenter: Vincenzo Minotti | Author(s): Sara Baglivo, Fortunato Bianconi, Francesca Romana Tofanetti, Biagio Ricciuti, Lorenza Pistola, Annamaria Siggillino, Maria Sole Reda, Giulio Metro, Guido Bellezza, Fausto Roila, Vienna Ludovini
- Abstract
Loading... -
+
P1.01-66 - A CT-Based Radiomics Approach to Predict PD1 Inhibitor Response in Non-Small-Cell Lung Cancer
09:45 - 09:45 | Presenter: Jialei Wang | Author(s): Shengping Wang, Hui Yu, Chang Liu, Xinmin Zhao, Si Sun, Jianhua Chang, Jie Qiao, Xianghua Wu
- Abstract
Loading... -
+
P1.01-67 - Ph I/II Carboplatin, Nab-Paclitaxel and Pembrolizumab for Advanced NSCLC (HCRN LUN13-175): Outcomes by Nab-Paclitaxel Dose
09:45 - 09:45 | Presenter: Ryan D Gentzler | Author(s): Nisha Anjali Mohindra, Shadia I Jalal, Karen L Reckamp, Richard D Hall, Nasser Hanna, Young Kwang Chae, Victoria Meucci Villaflor, Marianna Koczywas, Irene B Helenowski, Alfred W Rademaker, Jyoti D Patel
- Abstract
Loading... -
+
P1.01-68 - Monitoring Clinical Responses Measuring PD-L1 in cfRNA in Plasma of Non-Small Cell Lung Cancer Patients Undergoing Systemic Therapy
09:45 - 09:45 | Presenter: Luis Raez | Author(s): Joshua Usher, Kathleen Danenberg, Daniel Sumarriva, Brian Hunis, Gelenis Domingo, Yolanda Jaimes, Peter Danenberg, Shahrooz Rabizadeh
- Abstract
Loading... -
+
P1.01-69 - Blood Serum Amyloid A as Potential Predictor of Response to First-Line Pembrolizumab in Patients with Advanced Non-Small-Cell Lung Cancer
09:45 - 09:45 | Presenter: Vincenzo Di Noia | Author(s): Carmine Carbone, Emanuele Vita, Miriam Ferrara, Ettore D'Argento, donatella Lucchetti, Paola Damiano, Antonella Virtuoso, Marta Ribelli, Antonella Cannella, Alessandra Battaglia, Andrea Fattorossi, Alessandro Sgambato, Giampaolo Tortora, Emilio Bria
- Abstract
Loading... -
+
P1.01-70 - Dominant Circulating Myeloid Populations Are Associated with Poor Response in NSCLC Treated with 1st Line PD-1 Monotherapy
09:45 - 09:45 | Presenter: Sally CM Lau | Author(s): Lisa Le, Sze Wah Samuel Chan, Elliot Smith, Malcolm Ryan, M Catherine Brown, Katrina Hueniken, Lawson Eng, Devalben Patel, Rui Qi Chen, Mike Sung, Alona Zer, Penelope A Bradbury, Pamela S Ohashi, Frances Shepherd, Ming Sound Tsao, Natasha B Leighl, Geoffrey Liu, Adrian G Sacher
- Abstract
Loading... -
+
P1.01-71 - Bone Metastases and Skeletal-Related Events in Patients with Metastatic NSCLC Treated with ICIs: A Multi-Institutional Study
09:45 - 09:45 | Presenter: Angel Qin | Author(s): Songzhu Zhao, Abdul Miah, Lai Wei, Sandip Patel, Andrew Johns, Madison Grogan, Erin M. Bertino, Kai He, Sope O Olugbile, Peter Shields, Gregory Kalemkerian, Shirish Gadgeel, Nithya Ramnath, Bryan J. Schneider, Khaled Hassan, David P Carbone, Carolyn J Presley, Gregory A Otterson, Dwight Hall Owen
- Abstract
Loading... -
+
P1.01-72 - A Phase II Study of Selective AXL Inhibitor Bemcentinib and Pembrolizumab in Patients with NSCLC Refractory to Anti-PD(L)1
09:45 - 09:45 | Presenter: Matthew Krebs | Author(s): Paal Brunsvig, Åslaug Helland, Nuria Viñolas, Santiago Ponce Aix, Enric Carcereny, Manuel Dómine, Jose Manuel Trigo Perez, Edurne Arriola, Rosario Garcia Campelo, James Spicer, Jonathan Robert Thompson, Ana Laura Ortega Granados, Robert J. Holt, Dominic Smethurst, James B. Lorens, Muhammad Shoaib, Abdul Siddiqui, Julia Schoelermann, Katherine Lorens, Emmett V. Schmidt, Michael Jon Chisamore, Enriqueta Felip
- Abstract
Loading... -
+
P1.01-73 - An Explorative Analysis of Pemetrexed +/- Pembrolizumab Maintenance from KEYNOTE-189 Versus PARAMOUNT, PRONOUNCE, and JVBL
09:45 - 09:45 | Presenter: Edward Garon | Author(s): Ramaswamy Govindan, Vassiliki A Papadimitrakopoulou, Chunxiao Wang, Rocio Varea, Jong Seok Kim, Joachim G.J.V. Aerts
- Abstract
Loading... -
+
P1.01-74 - A Retrospective Study Evaluating Clinical Predictors of Duration of Response to Immune Checkpoint Inhibitors in Advanced NSCLC
09:45 - 09:45 | Presenter: Yahya Ibrahim | Author(s): Keerthana Sankar, Hassan Mouzaihem, Seongho Kim, Amy Haddad, Hirva Mamdani
- Abstract
Loading... -
+
P1.01-75 - Prognostic Impact of Neutrophil-to-Lymphocyte Ratio (NLR) for Advanced Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Masashi Ishihara | Author(s): ryosuke Ochiai, Terunobu Haruyama, Yoichi Tagami, Takahiko Sakamoto, Shigeru Tanzawa, Takeshi Honda, Shuji Ota, Yasuko Ichikawa, Kiyotaka Watanabe, Nobuhiko Seki
- Abstract
Loading... -
+
P1.01-76 - Randomized Phase II Study of Immunotherapy With or Without Low Dose Chemotherapy for Patients with Performance Status of 2
09:45 - 09:45 | Presenter: W. Jeffrey Petty | Author(s): Tamjeed Ahmed, Jimmy Ruiz, Thomas Lycan, Safoa Addo, Payal Gandhi, Jennifer Miller, Beverly Levine, Pierre Triozzi, Marcelo Bonomi
- Abstract
Loading... -
+
P1.01-77 - Impact of Oral Drugs on the Prognosis of Non-Small-Cell Lung Cancer Patients Treated with Nivolumab
09:45 - 09:45 | Presenter: Yoshihiko Taniguchi | Author(s): Akihiro Tamiya, Shun-ichi Isa, Kenji Nakahama, Kyoichi Okishio, Takayuki Shiroyama, Hidekazu Suzuki, Takako Inoue, Motohiro Tamiya, Tomonori Hirashima, Fumio Imamura, Shinji Atagi
- Abstract
Loading... -
+
P1.01-78 - Treatment-Related Adverse Events in Patients with Advanced NSCLC Treated with First-Line Atezolizumab Chemoimmunotherapy
09:45 - 09:45 | Presenter: Kyaw Zin Thein | Author(s): Sriman Swarup, Anita Sultan, Nusrat Jahan, Miguel Quirch, Srikala Meda, Thura Win Htut, Nimesh Adhikari, Pwint Phyu Hlaing, Akshar Dash, Aung Myint Tun, Shabnam Rehman, Fred Hardwicke, Lukman Tijani
- Abstract
Loading... -
+
P1.01-79 - G8 Screening Scores in Elderly Advanced Lung Cancer Patients: A Prospective Single Institution Study
09:45 - 09:45 | Presenter: Xiaorong Wu | Author(s): Urska Janzic, Charlotte Milner-Watts, Dave Walder, Rajiv Kumar, Anna Minchom, Ranga Gunapala, Jaishree Bhosle, Mary O'Brien
- Abstract
Loading... -
+
P1.01-80 - Lung Cancer Prognostic Index Performance in US Real-World Advanced Non-Small Cell Lung Cancer Patients
09:45 - 09:45 | Presenter: Roma Shah | Author(s): Ani John, Marliese Alexander
- Abstract
Loading... -
+
P1.01-81 - A New Prognostic Index Combines the Metabolic Response and RECIST 1.1 to Evaluate the Therapeutic Response in Patients with Lung Cancer
09:45 - 09:45 | Presenter: Wenfang Tang | Author(s): Qingyi Hou, Juntao Lin, Zhongyi Dong, Yangsi Li, Jinghua Chen, Honghong Yan, Shuxia Wang, Yi-Long Wu, Wen-Zhao Zhong
- Abstract
Loading... -
+
P1.01-82 - The Different Frequencies and Genetic Profiles of Histologic Transformation After Different EGFR-TKIs in EGFR-Mutant Adenocarcinomas
09:45 - 09:45 | Presenter: Jin Kang | Author(s): Hua-Jun Chen, Bin-Chao Wang, Zhen Wang, Xu-Chao Zhang, Xiang-Meng Li, Qiu-Mei Deng, Yi-Long Wu, Jin-Ji Yang
- Abstract
Loading... -
+
P1.01-83 - Comparative Efficacy Analysis Between Entrectinib Trial and Crizotinib Real-World ROS1 Fusion-Positive (ROS1+) NSCLC Patients
09:45 - 09:45 | Presenter: Robert C. Doebele | Author(s): Laura Perez, Huong Trinh, Michael Martinec, Reynaldo Martina, Todd Riehl, Matthew G Krebs, Neal J. Meropol, Will Wong, Gracy Crane
- Abstract
Loading... -
+
P1.01-84 - Interaction of Lorlatinib with CYP2B6, CYP2C9, UGT, and P-gp Probe Drugs in Patients with Advanced Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Joseph Chen | Author(s): Alessandra Bearz, Dong-Wan Kim, Hirva Mamdani, Jessica R Bauman, Rita Chiari, Sai-Hong Ignatius Ou, Benjamin J Solomon, Ross Soo, Enriqueta Felip, Alice T. Shaw, Jill S. Clancy, Kimberly Lee, Melissa O'Gorman, Cherie Tanski, Yazdi K. Pithavala
- Abstract
Loading... -
+
P1.01-85 - Treatment for Advanced NSCLC with EGFR Mutations and De Novo MET Amplification/Overexpression
09:45 - 09:45 | Presenter: Han-Min Wang | Author(s): Wen-feng Li, Qiu-Mei Deng, Jin Kang, Hua-Jun Chen, Zhen Wang, Qing Zhou, Chongrui Xu, Xu-Chao Zhang, Jian Su, Honghong Yan, Yi-Long Wu, Jin-Ji Yang
- Abstract
Loading... -
+
P1.01-86 - Occurrence of de Novo Dual HER2/HER3 or HER2/EGFR TMD Mutations: Extending the Spectrum of Targetable Mono-HER2 TMD in NSCLC?
09:45 - 09:45 | Presenter: Sai-Hong Ignatius Ou | Author(s): Alexa Betzig Schrock, Eduard V Bocharov, Jessica Lee, Russell Madison, Laurie Gay, Vincent A Miller, Brian Alexander, Hatim Husain, Jonathan Wesley Riess, Siraj M Ali, Vamsidhar Velcheti
- Abstract
Loading... -
+
P1.01-87 - Acquired Resistance Mechanisms and Clinical Outcomes for Patients with Epidermal Growth Factor Receptor (EGFR) Positive Non-Small Cell Lung Cancer (NSCLC) Treated with Osimertinib
09:45 - 09:45 | Presenter: Tejas Patil | Author(s): Anastasios Dimou, Jose Pacheco, Derek E Smith, Dara Aisner, Dan Merrick, Chad Rusthoven, Brian Kavanaugh, Ronni Miller, Erin Schenk, D. Ross Camidge, Paul A Bunn, Jr, Robert C. Doebele
- Abstract
Loading... -
+
P1.01-88 - PS 2 Patients with Advanced EGFR Mutant NSCLC: Subset Analysis of a Phase III Randomized Trial Comparing Gefitinib to Gefitinib with Chemotherapy
09:45 - 09:45 | Presenter: Kumar Prabhash | Author(s): Vanita Noronha, Vijay Maruti Patil, Amit Joshi, Anuradha Chougule
- Abstract
Loading... -
+
P1.01-89 - A Multicenter Phase 1/2a Trial of CLN-081 in NSCLC with EGFR Exon 20 Insertion Mutations
09:45 - 09:45 | Presenter: Zofia Piotrowska | Author(s): David Planchard, Myles Steven Clancy, David Witter, Leigh Zawel, Helena A Yu
- Abstract
Loading... -
+
P1.01-90 - Update Phase II Results of Early Primary Tumor Stereotactic Body Radiotherapy Combined with First-Line EGFR-TKI in Advanced EGFR Mutated NSCLC
09:45 - 09:45 | Presenter: Dongqing Lv | Author(s): Hailin Xu, Yinnan Meng, Wei Wang, Xiaomai Wu, Feng-Ming Spring Kong, Haihua Yang
- Abstract
Loading... -
+
P1.01-91 - Clinical Outcomes of Various Resistance Mechanisms of Osimertinib in Chinese Advanced Non-Small Cell Lung Cancer Patients
09:45 - 09:45 | Presenter: Puyuan Xing | Author(s): Yuxin Mu, Shouzheng Wang, Di Ma, Jing Lin, Hao Liu, Han Han-Zhang, Analyn Lizaso, Jianxing Xiang, Xinru Mao, Xuezhi Hao, Junling Li
- Abstract
Loading... -
+
P1.01-92 - Underlying Mechanisms That Potentially Affect Prognosis to EGFR-TKI in EGFR-Positive Patients with Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Ying Cheng | Author(s): Lixia Ma, Ying Liu, Ying Xin, Yan Chen, Jing Zhu, Liang Zhang, Changliang Yang, Chunjiao Wu, Tingting Zhang, Sheng Wang, Zili Li, Lianwei Bai, Xinru Mao, Tengfei Zhang, Jing Lin, Liming Shi
- Abstract
Loading... -
+
P1.01-93 - Metastases Sites as a Prognostic Factor in a Real-World Multicenter Cohort Study of Spanish ALK-Positive NSCLC Patients (p)
09:45 - 09:45 | Presenter: Laura Angelats | Author(s): Rosario Garcia Campelo, Reyes Bernabe, Edurne Arriola, Pedro Rocha, Virginia Calvo De Juan, Elia Sais, Andrés Barba, Nuria Viñolas, MDLL Gil Moreno, Laia Vilà, Oscar Juan, Noelia Vilariño, Manuel Cobo, Manuel Dómine, Sergio Vazquez, Juan Coves, Raquel Marse-Fabregat, Ana Maria Esteve Gomez, Enric Carcereny
- Abstract
Loading... -
+
P1.01-94 - JNJ-61186372, an EGFR-cMet Bispecific Antibody, in EGFR Exon 20 Insertion-Driven Advanced NSCLC
09:45 - 09:45 | Presenter: Byoung Chul Cho | Author(s): Jiyeon Yun, Han Na Kang, Soo-Hwan Lee, Chae-Won Park, Seo-Yoon Jeong, Min Hee Hong, Hye Ryun Kim, Meena Thayu, Joshua C Curtin, Roland E Knoblauch, Matthew V Lorenzi, Amy Roshak
- Abstract
Loading... -
+
P1.01-95 - Efficacy and Safety of Anlotinib in Combination with Chemotherapy as First-Line Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
09:45 - 09:45 | Presenter: Tianqing Chu | Author(s): Baohui Han, Xueyan Zhang, Hua Zhong, Bo Zhang, Huimin Wang, Aiqin Gu, Wei Zhang, Chunlei Shi, Runbo Zhong
- Abstract
Loading... -
+
P1.01-96 - US Real-World Management of EGFR-Mutated Advanced NSCLC: Survival After First-Line EGFR-Tyrosine Kinase Inhibitor Treatment
09:45 - 09:45 | Presenter: Jorge Nieva | Author(s): Karen L Reckamp, Aliki Taylor, Bharat Thakrar, Jennifer L Wong, Danielle Potter, Nicolaas A. Bakker, Wendy S Rubinstein, Ping Sun
- Abstract
Loading... -
+
P1.01-97 - Modified RANO-LM Criteria to Evaluate the Radiological Response of Osimertinib in EGFR T790M Positive NSCLC with Leptomeningeal Metastases
09:45 - 09:45 | Presenter: Sehhoon Park | Author(s): Minjung Seong, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Sung Tae Kim, Myung-Ju Ahn
- Abstract
Loading... -
+
P1.01-98 - Outcomes in Advanced NSCLC Patients Treated with 1st Line EGFR-TKI Based on Mutation Detection from Tissue or cfDNA-Based Genomic Sequencing
09:45 - 09:45 | Presenter: Hai Tran | Author(s): Vincent Lam, Mayra Vasquez, Lingzhi Hong, Rivka Colen, Nabil Elshafeey, Islam Hassan, Vassiliki A Papadimitrakopoulou, George Blumenschein Jr, Brett Carter, George R Simon, Richard B Lanman, Victoria Raymond, Yasir Elamin, Mehmet Altan, Anne Tsao, Don Lynn Gibbons, Jianjun Zhang, John Victor Heymach
- Abstract
Loading... -
+
P1.01-99 - EGFR-Wild Type Patients Responding to TKI: Revisiting Pathology with Newer Technology
09:45 - 09:45 | Presenter: Jason Scott Agulnik | Author(s): Andreas Papadakis, Goulnar Kasymjanova, David Small, Carmela Pepe, Lama Sakr, George Chong, Hangjun Wang, Alan Spatz, Victor Cohen
- Abstract
Loading...
-
+
P1.03 - Biology
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Biology
-
+
P1.03-01 - Polymorphisms in Glycolysis-Related Genes Are Associated with Clinical Outcomes of Paclitaxel-Cisplatin Chemotherapy in NSCLC
09:45 - 09:45 | Presenter: Sun Ha Choi | Author(s): JIEUN Park, Sook Kyung Do, Jin Eun Choi, Ji Yun Jeong, Seung Soo Yoo, Shin Yup Lee, Eungbae Lee, Jae Yong Park
- Abstract
Loading... -
+
P1.03-02 - Nintedanib Selectively Inhibits Angiogenesis Induced by the Conditioned Medium of Lung Adenocarcinoma TAFs in Vitro
09:45 - 09:45 | Presenter: Natalia Isabel Díaz-Valdivia | Author(s): Paula Duch, Rafael Ikemori, Marta Gabasa, Frank Hilberg, Noemi Reguart, Jordi Alcaraz
- Abstract
Loading... -
+
P1.03-03 - Inhibition of H1299 Lung Cancer Cell Proliferation and Survival by Rosemary Extract Is Associated with AMPK Activation
09:45 - 09:45 | Presenter: Evangelia Litsa Tsiani
- Abstract
Loading... -
+
P1.03-04 - Use Supernatant of Malignant Pleural Effusion to Identify Driver Mutants and Monitor Response to Targeted Therapy
09:45 - 09:45 | Presenter: Rui Lin | Author(s): Yuehong Wang, Shanshan Xiao, Ruifang Mao, Tao Wang
- Abstract
Loading... -
+
P1.03-05 - COMMD4 in Lung Cancer: Towards a New Therapeutic Target and Diagnostic Biomarker
09:45 - 09:45 | Presenter: Kenneth John O’Byrne | Author(s): Amila Suraweera, Mark Adams, Christian Jekimovs, Derek Richard
- Abstract
Loading... -
+
P1.03-06 - Integrative Omics Analysis Reveals Important Roles of Adenosine Diphosphate in Haemostasis and Platelet Activation in NSCLC
09:45 - 09:45 | Presenter: Long Hoang | Author(s): Clara Domingo-Sabugo, Elizaberth Starren, Saffron A G Willis-Owen, Andrew G Nicholson, Deborah Morris-Rosendahl, Miriam F Moffatt, William O.C Cookson
- Abstract
Loading... -
+
P1.03-07 - Advantages and Setbacks of EGFR Mutation Testing from Liquid Biopsy of Advanced Lung Adenocarcinoma Patients in Serbia
09:45 - 09:45 | Presenter: Jelena Spasic | Author(s): Ana Krivokuca, Ivana Boljevic, Marijana Pavlovic, Jelena Rakobradovic, Vera Jokic, Davorin Radosavljevic, Emina Malisic, Radmila Jankovic, Milena Cavic
- Abstract
Loading... -
+
P1.03-08 - RNF43 Ubiquitinates and Degrades Phosphorylated E-Cadherin by c-Src to Facilitate Epithelial-Mesenchymal Transition in Lung Adenocarcinoma
09:45 - 09:45 | Presenter: Yang Zhao
- Abstract
Loading... -
+
P1.03-09 - Atypical Ubiquitin as a Molecular Target in Lung Cancer
09:45 - 09:45 | Presenter: Seshiru Nakazawa | Author(s): Kimihiro Shimizu, Takashi Ibe, Kai Obayashi, Natsuko Kawatani, Toshiki Yajima, Ken Shirabe
- Abstract
Loading... -
+
P1.03-10 - High-Risk Growth Patterns of Lung Adenocarcinoma Show Distinct Modes of Metastasis and Recurrence
09:45 - 09:45 | Presenter: Marco Sereno | Author(s): Claire Smith, John Le Quesne
- Abstract
Loading... -
+
P1.03-11 - Molecular Testing of Small Bronchoscopy Specimens Using NanoString Technology
09:45 - 09:45 | Presenter: Brielle Anne Parris | Author(s): Ian Yang, Rayleen Bowman, Kwun M Fong
- Abstract
Loading... -
+
P1.03-12 - Preclinical Validation of an Epigenetic Panel of Seven miRNAs at Early Stages NSCLC Patients and Its Prognostic Implications
09:45 - 09:45 | Presenter: Dario Sanchez Cabrero | Author(s): Patricia Cruz, Olga Pernia, Olga Vera, Isabel Esteban, Rocio Rosas, Julia Jimenez, Itsaso Losantos, Javier De Castro Carpeno, Inmaculada Ibañez
- Abstract
Loading... -
+
P1.03-13 - Genomic Landscape of Brazilian Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Letícia Ferro Leal | Author(s): Pedro De Marchi, Luciane Sussuchi Da Silva, Flávio Augusto Ferreira Da Silva, Lazaro Antonio Campanha Novaes, Ysadhora Christiane Camargo Rodrigues, Wellington Dos Santos, Eduardo Caetano Albino Da Silva, Adriane Feijó Evangelista, Rui Manuel Reis
- Abstract
Loading... -
+
P1.03-14 - HLA-E and FAT1 in Head and Neck and Lung Cancer. The Effect of Osimertinib or Olmutinib with Artesunate (Dihydroartemisinin)
09:45 - 09:45 | Presenter: Imane Chaib | Author(s): Rafael Rosell, Peng Cao, Niki Karachaliou, Xueting Cai, Mario Hermsen, David Llige Santafe, Mariacarmela Santarpia, Maria Gonzalez-Cao, Fabiana Letizia Cecere, Martyna Filipska, Carlos Pedraz, Jillian Wilhelmina Paulina Bracht, Masaoki Ito, Andrés Aguilar Hernandez, Jordi Codony-Servat, Andrés Felipe Cardona
- Abstract
Loading... -
+
P1.03-15 - Non-Invasive Detection of Secondary Resistance Mutations in ALK-Positive NSCLC Patients by Next-Generation Sequencing
09:45 - 09:45 | Presenter: Atocha Romero | Author(s): Estela Sánchez Herrero, Miguel Barquin, Virginia Calvo De Juan, Milda Auglyte, Rosario Garcia Campelo, José Miguel Sánchez, Manuel Dómine, Bartomeu Massuti, Eloisa Jantus, Carlos Camps, Noemi Reguart, Mariano Provencio
- Abstract
Loading... -
+
P1.03-16 - Anti-Tumor Effect of Pan-RAF Inhibitor in NSCLC Cells Harboring BRAF Mutation
09:45 - 09:45 | Presenter: Shunsaku Miyauchi | Author(s): Kazuhiko Shien, Kota Araki, Kentaro Nakata, Akihiro Miura, Kei Namba, Ken Suzawa, Hiromasa Yamamoto, Mikio Okazaki, Shuta Tomida, Shinichi Toyooka
- Abstract
Loading... -
+
P1.03-17 - Function of Antisense LncRNA RP11-539E17.5 and FAM83A-AS1 Up-Regulating FAM83A in Lung Adenocarcinoma Tumorigenesis and Development
09:45 - 09:45 | Presenter: Xuequan Wang | Author(s): Wei Wang, Yinnan Meng, Suna Zhou, Feng-Ming Spring Kong, Haihua Yang
- Abstract
Loading... -
+
P1.03-18 - OCIAD2 Impairs Mitochondria-Mediated Apoptosis Through Substantial Alteration of Crista Structure in Lung Adenocarcinoma
09:45 - 09:45 | Presenter: Jeongmin Hong | Author(s): Yunjung Kim, Aya Shiba-Ishii, Masayuki Noguchi
- Abstract
Loading... -
+
P1.03-19 - Circulating Tumour Cells in Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Kenneth John O’Byrne
- Abstract
Loading... -
+
P1.03-20 - Exploring Driver Mutations in Non-Coding RNAs in Lung Adenocarcinoma
09:45 - 09:45 | Presenter: Alvaro Andrades | Author(s): Isabel Fernández Coira, María Isabel Rodríguez, Pedro Carmona-Sáez, Javier De Las Rivas, Marta Cuadros, Pedro Pablo Medina
- Abstract
Loading... -
+
P1.03-21 - Epigenome-Wide Association Study of Cancer Associated Fibroblasts-Induced Oncogenic Transformation of Lung Epithelial Cells
09:45 - 09:45 | Presenter: Sheng-Fang Su | Author(s): Hao Ho, Huei-Wen Chen, Chao-Chi Ho, Ker-Chau Li
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.03-23 - Delta-Like 1 Homolog (DLK1) Expression in Non-Small-Cell Lung Cancer and the Development of Radioimmunotherapy Targeting DLK1
09:45 - 09:45 | Presenter: Hironori Takagi | Author(s): Songji Zhao, Satoshi Muto, Hayato Mine, Masayuki Watanabe, Yuki Ozaki, Naoyuki Okabe, Takeo Hasegawa, Yutaka Shio, Miho Aoki, Chengbo Tan, Saki Shimoyama, Koji Nakamura, Akihiro Inano, Hiroyuki Suzuki
- Abstract
Loading... -
+
P1.03-24 - Thoracic Injection of PD-1 Blocking Antibody Improves the Murine Model of Malignant Pleural Effusion
09:45 - 09:45 | Presenter: Tangfeng Lv | Author(s): Xin-ying Li, Guannan Wu, Cen Chen, Yuan Zhao, Jie Yin, Yong Song
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.03-26 - Genetic and Molecular Profiling of Non-Smoking Related Lung Adenocarcinomas
09:45 - 09:45 | Presenter: Eva Pros | Author(s): Maria Saigi, Juan José Alburquerque Béjar, María José Pajares, Beatriz Martinez-Delgado, Julian Carretero, Raul Tonda, Anna Esteve-Codina, Sara Verdura, Isabel Català, Noemi Reguart, Oscar Juan, Ernest Nadal, Enriqueta Felip, Luis M Montuenga, Montse Sanchez-Cespedes
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.03-28 - Prognostic Value of Estrogen Receptor Beta Tumor Expression in Non-Small Cell Lung Cancer Patients After Radical Surgery
09:45 - 09:45 | Presenter: Anna Basharina | Author(s): Tatiana Bogush, Elena Bogush, Anna Grishanina, Olga Ryabinina, Nadezhda Vichlzantseva, Sergei Kolomiytsev, Boris Polotsky
- Abstract
Loading... -
+
P1.03-29 - Cellular Biology Determines Ability of XIST to Act as a miRNA Sponge in Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Greg L Stewart | Author(s): Erin A Marshall, Adam P Sage, Wan Lam, Carolyn J Brown
- Abstract
Loading... -
+
P1.03-30 - Transcriptome Signatures of Tobacco Carcinogens on Lung Adenocarcinoma Cell Lines
09:45 - 09:45 | Presenter: Mario Pepe | Author(s): Anne Sophie Lamort, Nikolaos I Kanellakis, Francesco Pelizza, Μagda Spella, Georgios T Stathopoulos
- Abstract
Loading... -
+
P1.03-31 - BRAF Mutations: Classes I, II and III in NSCLC Patients Included in the SLLIP Trial, Targeted Treatment According to Class
09:45 - 09:45 | Presenter: Jillian Wilhelmina Paulina Bracht | Author(s): Niki Karachaliou, Trever G Bivona, Manuel Fernández-Bruno, Jordi Berenguer, Maria Gonzalez-Cao, Richard B Lanman, Iris Faull, Rebecca Nagy, Ana Drozdowskyj, Andrés Aguilar Hernandez, Juan Jose Garcia Mosquera, Miguel Angel Molina-Vila, Rafael Rosell
- Abstract
Loading... -
+
P1.03-32 - Knockdown of CENPF Gene Inhibits the Progression of Lung Adenocarcinoma Mediated by ERβ2/5 Pathway
09:45 - 09:45 | Presenter: Hexiao Tang | Author(s): Yuquan Bai, Lecai Xiong, Jinping Zhao, Michael Lanuti
- Abstract
Loading... -
+
P1.03-33 - Analysis of Lipid Metabolism Genes in Advanced Small Cell Lung Cancer
09:45 - 09:45 | Presenter: María Sereno Moyano | Author(s): María Merino, Lara P. Fernández, Ana Ramírez De Molina, Juan Moreno Rubio, Gonzalo Colmenarejo, César Gómez Raposo, Miriam López Gómez, Sandra Falagán Martínez, Cristina Aguayo Zamora, Francisco Zambrana Tévar, Ana María Jiménez Gordo, Enrique Casado Sáez
- Abstract
Loading... -
+
P1.03-34 - The lncRNA NEAT1 Promotes Radioresistance via the MiR-491-5p/CAPG Axis in NSCLC
09:45 - 09:45 | Presenter: Suna Zhou | Author(s): Haihua Yang
- Abstract
Loading... -
+
P1.03-35 - Analysis of TET2 Gene Aberrations in East Asian Non-Small-Cell Lung Cancer Patients and Evaluation of Their Prognosis
09:45 - 09:45 | Presenter: Chunwei Xu | Author(s): Yinbin Zhang, Wenxian Wang, Quxia Zhang, Wu Zhuang, Youcai Zhu, Zhangzhou Huang, Gang Chen, Meiyu Fang, Tangfeng Lv, Yong Song
- Abstract
Loading... -
+
P1.03-36 - Cell-Free DNA Levels in Liquid Biopsy from Patients with Non-Small Cell Lung Cancer and Association with Clinical Parameters and Disease Outcome
09:45 - 09:45 | Presenter: Letícia Ferro Leal | Author(s): Natalia Zampieri Pontes, Flávio Augusto Ferreira Da Silva, Ysadhora Christiane Camargo Rodrigues, Pedro De Marchi, Andre Lengert, Rui Manuel Reis
- Abstract
Loading... -
+
P1.03-37 - Impacts of DSB Repair Protein, NBS1, on Lung Cancer
09:45 - 09:45 | Presenter: Yu-Feng Wei | Author(s): Yao-Tsung Yeh, Jiun-Ting Wu, Ming- Shyan Huang
- Abstract
Loading... -
+
P1.03-38 - EGFR Mutation Status as a Prognostic Marker in Stage 1 Lung Adenocarcinoma After Definitive Surgical Resection
09:45 - 09:45 | Presenter: Carlos Galvez | Author(s): Saya Jacob, Jeffrey Zhao, Kyle Tegtmeyer, Brian Finkelman, Young Kwang Chae, Nisha Anjali Mohindra, Borko Jovanovic, Amir Behdad, Victoria Meucci Villaflor
- Abstract
Loading... -
+
P1.03-39 - Intra-Tumoral CD61+ Megakaryocytes Predicts Poor Prognosis in Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Wenhua Liang | Author(s): Weizhe Huang, Jianxing He, Qihua He
- Abstract
Loading... -
+
P1.03-40 - Using Model Systems to Improve Outcomes for Early Stage NSCLC
09:45 - 09:45 | Presenter: Matthew Allen Steliga | Author(s): Jason L Muesse, Ik Jae Shin, Konstantinos Arnaoutakis, Sanjay Maraboyina, Susanne K Jeffus, Sergio Pina Oviedo, Erich A Peterson, Donald J Johann
- Abstract
Loading... -
+
P1.03-41 - Chronic Nicotine Exposure Affects PD-L1 Expression and Sensitivity to EGFR-TKI in Lung Cancer
09:45 - 09:45 | Presenter: Changdong Yeo | Author(s): Sang Haak Lee, In Kyoung Kim, Hye Seon Kang
- Abstract
Loading... -
+
P1.03-42 - Angiotensin System Inhibitors Improve Survival in Stage IIIA NSCLC and Show Anti-Tumor Effect in Combination with Chemotherapy in a Model of NSCLC
09:45 - 09:45 | Presenter: Hexiao Tang | Author(s): Mozhdeh Sojoodi, Shen Li, Derek Erstad, Sarani Ghoshal, Gunisha Arora, Eric Abston, Kenneth K Tanabe, Bryan Fuchs, Michael Lanuti
- Abstract
Loading... -
+
P1.03-43 - Preoperative Prognostic Value of Immune-Inflammation Index in Patients with Operable Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Carlos Alfredo Fraile Olivero | Author(s): Lucia Milla Collado, Mario Mecho Carratala, Amaia Ojanguren Arranz, Javier Trujillano Cabello, Carlos Cerdan Santacruz, Mario Montesinos, Carlos Rombolá
- Abstract
Loading... -
+
P1.03-44 - Role of Serum Procalcitonin as Diagnostic Biomarker of Pneumonia in Lung Cancer Patient
09:45 - 09:45 | Presenter: Atit Puspitasari Dewi | Author(s): Erlina Burhan, Andika Chandra Putra
- Abstract
Loading... -
+
P1.03-45 - Circulating Tumor Cells' Clearance in Blood Samples After Chemotherapy: A Good Prognostic Factor for OS in Advanced NSCLC
09:45 - 09:45 | Presenter: Lucia Milla Collado | Author(s): Carlos Alfredo Fraile Olivero, Carlos Cerdan Santacruz, Teresa Valverde Higueras, Jose Luis Gonzalez Larriba, Isabel Cal Vazquez, José Ramón Jarabo Sarceda, Elena Fernández Martín, Florentino Hernando-Trancho
- Abstract
Loading... -
+
P1.03-47 - KEAP1 Mutations in East Asian Patients with NSCLC: An Investigation of Prevalence, Clinicopathologic Characteristics and Prognosis
09:45 - 09:45 | Presenter: Chunwei Xu | Author(s): Zongyang Yu, Wenxian Wang, Quxia Zhang, Wu Zhuang, Youcai Zhu, Zhangzhou Huang, Gang Chen, Meiyu Fang, Tangfeng Lv, Yong Song
- Abstract
Loading... -
+
P1.03-48 - Vasohibin 2 Promotes Angiogenesis and Lymphangiogenesis of Lung Squamous Cell Carcinoma Through Snail-Dependent VEGF-D Signaling Pathway
09:45 - 09:45 | Presenter: Pengpeng Liu | Author(s): Lei Han, Rui Zhang, Weijia Zhang, Jinpu Yu
- Abstract
Loading... -
+
P1.03-49 - Systematic Dysregulation of Cell Cycle by lncRNAs in Lung Adenocarcinoma
09:45 - 09:45 | Presenter: Xiaoshun Shi | Author(s): Allen Menglin Chen, Zhouxia Zheng, Xiaoying Dong, Kailing Huang, Xiguang Liu, Di Lu, Siyang Feng, Kaican Cai
- Abstract
Loading... -
+
P1.03-50 - Type- and Stage-Specific Genomic Profiles in East Asian Lung Cancer Patients with No TKI-Related Driver Gene Mutations
09:45 - 09:45 | Presenter: Yayi He | Author(s): Xiaoxia Chen, Bin Chen, Lele Song, Xiaobin Li, Shifu Chen, Guifeng Liu, Caicun Zhou
- Abstract
Loading... -
+
P1.03-51 - MUC3A Induces PD-L1 and Reduces Tyrosine Kinase Inhibitor Effects in EGFR-Mutant Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Conghua Xie | Author(s): Yuan Luo
- Abstract
Loading...
-
+
P1.04 - Immuno-oncology
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P1.04-01 - Body Mass Index and Age Do Not Influence Survival in Patients with Lung Cancers Treated with PD1/PDL1 Immune Checkpoint Inhibitors
09:45 - 09:45 | Presenter: Corentin Richard | Author(s): Arielle Elkrief, Julie Malo, Lena Cvetkovic, Marie Florescu, Normand Blais, Mustapha Tehfe, Andréanne Gagné, Catherine Labbe, Michele Orain, Philippe Joubert, Francois Ghiringhelli, Bertrand Routy
- Abstract
Loading... -
+
P1.04-02 - Efficacy and Safety of Sintilimab with Anlotinib as First-Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC)
09:45 - 09:45 | Presenter: Baohui Han | Author(s): Tianqing Chu, Runbo Zhong, Hua Zhong, Bo Zhang, Wei Zhang, Chunlei Shi, jialin Qian, Yuchen Han
- Abstract
Loading... -
+
P1.04-03 - HLA Affinity for Mutant EGFR Derived Peptides Identifies a Group of Patients with EGFR Driven NSCLC and Favorable Prognosis
09:45 - 09:45 | Presenter: Anastasios Dimou | Author(s): Paul Grewe, Monica Campbell, Tonya Brunetti, John Sidney, Alessandro Sette, Adrie Van Bokhoven, Paul Norman, Robert C. Doebele
- Abstract
Loading... -
+
P1.04-04 - DNA Damage Response Gene Alterations Are Associated with High Tumor Mutational Burden and Clinical Benefit from PD-1 Axis Inhibition in NSCLC
09:45 - 09:45 | Presenter: Biagio Ricciuti | Author(s): Michael L Cheng, Gonzalo Recondo Jr., Renato Umeton, Mizuki Nishino, Lynette M Sholl, Mark Awad
- Abstract
Loading... -
+
P1.04-05 - PD-L1 Expression (SP263) in Lung Cancer and Paired Brain Metastases – A Single Center Study in 211 Patients
09:45 - 09:45 | Presenter: Sabina Berezowska | Author(s): Alexandra Kündig, Christian Fung, Amina Scherz, Adrian Ochsenbein, Evelyn Herrmann, Ekin Ermis, Ralph A Schmid, Ekkehard Hewer
- Abstract
Loading... -
+
P1.04-06 - Tumor Microenvironment Landscape in Lung Adenocarcinoma by Single-Cell Sequencing
09:45 - 09:45 | Presenter: Bo Mi Ku | Author(s): Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn
- Abstract
Loading... -
+
P1.04-07 - Immune Suppressive Microenvironment and Highly Clonal Concordance of TCR Repertoire in Brain Metastases from Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Yujin Kudo | Author(s): Cara Haymaker, Jiexin Zhang, Alexandre Reuben, Dzifa Yawa Duose, Junya Fujimoto, Sinchita Roy-Chowdhuri, Luisa Maren Solis, Hitoshi Dejima, Edwin Roger Parra Cuentas, Barbara Mino, Norihiko Ikeda, Rajyalakshmi Luthra, Don Lynn Gibbons, Jianjun Zhang, Frederick Lang, J. Jack Lee, Jason T. Huse, Humam Kadara, Ignacio Wistuba
- Abstract
Loading... -
+
P1.04-08 - Randomized Controlled Phase III Trial of Adjuvant Chemoimmunotherapy to Lung Cancer Patients: Results of Malignant Effusions
09:45 - 09:45 | Presenter: Hideki Kimura
- Abstract
Loading... -
+
P1.04-09 - Predictive Clinical and Molecular Features of Long-Term Survivors Receiving Immune Checkpoint Inhibitors for Stage 4 Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Aaron John Franke | Author(s): Scott J. Antonia, Eric B Haura, Alberto Chiappori, Tawee Tanvetyanon, Jhanelle Elaine Gray, Ben Creelan
- Abstract
Loading... -
+
P1.04-10 - Identification of Immunotherapy Targets in STK11 Mutant Non-Squamous Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Edwin Yau | Author(s): Sean T Glenn, Antonios Papinicalou-Sengos, Mary Nesline, Carl Morrison, Grace Dy
- Abstract
Loading... -
+
P1.04-11 - Depicting the Intra-Tumoral Viral and Microbial Landscape of Localized NSCLC Using Standard Next Generation Sequencing Data
09:45 - 09:45 | Presenter: Pierre-Olivier Gaudreau | Author(s): Nadim Ajami, Boris Sepesi, Tatiana Karpinets, Alexandre Reuben, Matthew Wong, Edwin Parra, Lorenzo Federico, Vancheswaran Gopalakrishnan, Kyle Gregory Mitchell, Marcelo Vailati Negrao, Christine Spencer, Ara A Vaporciyan, Annikka Weissferdt, Cara Haymaker, Hai Tran, Chantale Bernatchez, Lara Carolina Landry, Emily Roarty, Tina Cascone, John Victor Heymach, Jinhua Zhang, Ignacio Wistuba, Jianjun Zhang, Jennifer A Wargo, Don Lynn Gibbons
- Abstract
Loading... -
+
P1.04-12 - Tumor Uptake and Biodistribution of 89Zr-Labeled Pembrolizumab in Patients with Metastatic Non-Small-Cell Lung Cancer
09:45 - 09:45 | Presenter: Anna-Larissa Nadia Niemeijer | Author(s): Daniela Oprea-Lager, Marc C Huisman, Ronald Boellaard, Otto S Hoekstra, Linda De Wit - Van Der Veen, Idris Bahce, Danielle J Vugts, Guus AMS Van Dongen, Erik Thunnissen, Egbert F Smit, Joop De Langen
- Abstract
Loading... -
+
P1.04-13 - Delineating Spatial Heterogeneity of Tumor Mutational Burden (TMB) Counts in Pulmonary Adenocarcinoma
09:45 - 09:45 | Presenter: Daniel Kazdal | Author(s): Michael Allgäuer, Jan Budczies, Mark Kriegsmann, Jonas Leichsenring, Anna-Lena Volckmar, Martina Kirchner, Olaf Neumann, Regine Brandt, Eugen Rempel, Suranand Tala, Alexander Harms, Carolin Plögler, Moritz Von Winterfeld, Roland Penzel, Peter Schirmacher, Volker Endris, Albrecht Stenzinger
- Abstract
Loading... -
+
P1.04-14 - Early Changes in Plasma CXCL2 and MMP2 Levels Predicts the Response to Anti-PD-1 Therapy in Non-Small-Cell Lung Cancer
09:45 - 09:45 | Presenter: Norikazu Matsuo | Author(s): Koichi Azuma, kenta Murotani, Hidenobu Ishii, Takaaki Tokito, Kazuhiko Yamada, Yuji Shibata, Tadasuke Shimokawaji, Yoshiro Nakahara, Tetsuro Kondo, Terufumi Kato, Haruhiro Saito, Kouzo Yamada, Tetsuro Sasada, Tomoaki Hoshino
- Abstract
Loading... -
+
P1.04-15 - Smoking Status Is Not a Replacement Biomarker for Tumor Mutation Burden in Non-Small Lung Cancer
09:45 - 09:45 | Presenter: Kai He | Author(s): Michael Sharpnack, Ju Hwan Cho, Travis Johnson, Gregory A Otterson, Peter Shields, Kun Huang, David P Carbone
- Abstract
Loading... -
+
P1.04-16 - Early Antibiotic Use Affects the Efficacy of First Line Immunotherapy in Lung Cancer Patients but Route of Administration Seems to be Decisive
09:45 - 09:45 | Presenter: Xabier Mielgo Rubio | Author(s): Carlos Aguado, María Sereno, Luis Enrique Chara, Luis Cabezón, Alejandro Velastegui, Ana López, Rafael Lopez Castro, Miguel Sotelo, Judit Rubio, Juan Antonio Núñez, Elia Pérez Fernández, Clara Olier, Javier De Castro Carpeno, Mónica Antoñanzas, Sandra Falagan, Isabela Gomez-Barreda, Sara Custodio, Patricia Cruz
- Abstract
Loading... -
+
P1.04-17 - Phase I/II Study of Nivolumab and Vorolanib in Patients with Refractory Thoracic Tumors
09:45 - 09:45 | Presenter: Leora Horn | Author(s): Jennifer G. Whisenant, Kathryn E Beckermann, Hossein Borghaei, Taofeek Owonikoko, Jyoti D Patel, Lynn D. Berry, Yu Shyr, Kim Harrow, Chris Liang, Allison Holzhausen, Giovanni Selvaggi, Heather A Wakelee
- Abstract
Loading... -
+
P1.04-18 - Interleukin-5 Drives the Expansion of Pulmonary B-1 B Cells and Restricts Lung Tumor Growth
09:45 - 09:45 | Presenter: Rachel A Cederberg | Author(s): Alvina So, Elizabeth Franks, Michael R Hughes, Kelly M McNagny, Kevin L Bennewith
- Abstract
Loading... -
+
P1.04-19 - Association Between Efficacy and irAEs in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immune-Checkpoint Inhibitors
09:45 - 09:45 | Presenter: Mariona Riudavets | Author(s): Joaquin Mosquera, Rosario Garcia Campelo, Jorgina Serra, Georgia Anguera, Pablo Gallardo, Ivana G. Sullivan, Andrés Barba, Margarita Majem
- Abstract
Loading... -
+
P1.04-20 - PD-L1 mRNA Derived from Tumor-Educated Platelets Predicts the Clinical Outcome of Immunotherapy in Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Jianhua Chang | Author(s): Zhihuang Hu, Si Sun, Hui Yu, Xianghua Wu, Jialei Wang
- Abstract
Loading... -
+
P1.04-21 - Cellular Landscape of Normal Adjacent to Tumor Microenvironment in Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Yuan Li | Author(s): Long Wu, Yanlei Cheng, Weiping Tao
- Abstract
Loading... -
+
P1.04-22 - Potential DNA Repair Biomarker for Response to Immunotherapy of Lung Cancer Patients
09:45 - 09:45 | Presenter: Zvi Livneh | Author(s): Tamar Paz-Elizur, Yael Leitner-Dagan, Kerstin B. Meyer, Barak Barak Markus, Federico M. Giorgi, Martin O’reilly, Hyunjin Kim, Yentl Evgy, Robert C Rintoul, Bruce Ponder
- Abstract
Loading... -
+
P1.04-23 - Characterizing the Tumor Immune Microenvironment of Non-Small Cell Lung Carcinoma in People Living with HIV Using Imaging Mass Cytometry
09:45 - 09:45 | Presenter: Ramsey Yusuf | Author(s): Franz Villarroel-Espindola, Kurt A Schalper, Brinda Emu
- Abstract
Loading... -
+
P1.04-24 - Circulating Suppressive Immune Cells Predict the Efficacy of Anti PD-1 Immunotherapy in Patients with Advanced Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Jiae Koh | Author(s): Youjin Kim, Kyoung Young Lee, Mi Soon Kim, Bo Mi Ku, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn
- Abstract
Loading... -
+
P1.04-25 - CT Based Vessel Tortuosity Features Are Prognostic of Overall Survival and Predictive of Immunotherapy Response in NSCLC Patients
09:45 - 09:45 | Presenter: Pranjal Vaidya | Author(s): Mehdi Alilou, Pradnya Dinkar Patil, Pingfu Fu, Kaustav Bera, Vamsidhar Velcheti, Anant Madabhushi
- Abstract
Loading... -
+
P1.04-26 - EMT-Associated Response and Resistance to MEK Inhibitor and Immune Checkpoint Blockade Combinations in KRAS-Mutant NSCLC
09:45 - 09:45 | Presenter: Pierre-Olivier Gaudreau | Author(s): David H Peng, Bertha Leticia Rodriguez, Jared J Fradette, Laura A Gibson, Carminia M Della Corte, Charles M Rudin, Samrat T Kundu, Limo Chen, Jennifer A Wargo, Don Lynn Gibbons
- Abstract
Loading... -
+
P1.04-27 - Processing Escapes: Novel Resistance Mechanisms Under Immune Checkpoint Inhibition in NSCLC
09:45 - 09:45 | Presenter: Michael Wessolly | Author(s): Anna Streubel, Robert Werner, Sabrina Borchert, Susann Stephan-Falkenau, Sergej Griff, Elena Mairinger, Jan Schmeller, Robert Fred Henry Walter, Torsten Bauer, Wilfried Ernst Erich Eberhardt, Torsten Gerriet Blum, Kurt Werner Schmid, Jens Kollmeier, Fabian Dominik Mairinger, Thomas Mairinger
- Abstract
Loading... -
+
P1.04-28 - COAST: Durvalumab Alone or with Novel Agents for Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Roy S. Herbst | Author(s): Fabrice Barlesi, Luis Paz-Ares, David Raben, Charu Aggarwal, John Bothos, Ramin Samadani, Peng He, Natasha Angra, Pablo Martinez
- Abstract
Loading... -
+
P1.04-29 - Dynamic Changes of Plasma PD-L1 mRNA Expression Predict Response to Anti-PD-1/Anti-PD-L1 Treatment in Malignancies
09:45 - 09:45 | Presenter: Jianguo Sun | Author(s): Qiao Yang, Mingjing Chen, Jiaoyang Gu, Linpeng Zheng, Yongxin Yu, Feng Li, Luping Zhang, Kai Niu
- Abstract
Loading... -
+
P1.04-30 - Pioneer Study: Precision Immuno-Oncology for Advanced Non-Small Cell Lung Cancer Patients with PD1/L1 ICI Resistance
09:45 - 09:45 | Presenter: Fabrice Barlesi | Author(s): David Pérol, Julien Mazieres, Maurice Perol, Nathalie Varoqueaux, Florence Monville, Clarisse Audigier-Valette, Patricia Barre, François Domergue, Lionel Falchero, Cyril Foa, Ahmed Frikha, Stéphane Hominal, Jacques Le Treut, Sarah Zahi, Marie Roumieux, Daniel Olive, Eric Vivier
- Abstract
Loading... -
+
P1.04-31 - Immunosenescence Correlates with Poor Outcome from PD-(L)1 Blockade but Not Chemotherapy in Non-Small Cell Lung Cancer (NSCLC)
09:45 - 09:45 | Presenter: Roberto Ferrara | Author(s): Marie Naigeon, Edouard Auclin, Boris Duchemann, Lydie Cassard, Jean Jouniaux Medhi, Lisa Boselli, Jonathan Grivel, Aude Desnoyer, Matthieu Texier, Laura Mezquita, Frank Aboubakar, Lizza Hendriks, David Planchard, CAROLINE Caramella, Jordi Remon, Maud Ngocamus, Claudio Nicotra, Claudia Proto, Sabina Sangaletti, Nathalie Chaput, Benjamin Besse
- Abstract
Loading... -
+
P1.04-32 - Ki67+ PD-1+ Central Memory CD8 T-Cell Frequencies Predict Response Upon Nivolumab+Ipilimumab in Malignant Pleural Mesothelioma
09:45 - 09:45 | Presenter: Joanne Marijke Mankor | Author(s): Maria J. Disselhorst, Myrthe Poncin, Heleen Vroman, Paul Baas, Joachim G.J.V. Aerts
- Abstract
Loading... -
+
P1.04-33 - Deep Phenotyping of Immune Populations Reveals Baseline Predictors of Pembrolizumab Efficacy in NSCLC on KEYNOTE-001
09:45 - 09:45 | Presenter: Philippe Rochigneux | Author(s): Aaron Lisberg, Alejandro Garcia, Anne Sophie Chretien, Stephane Fattori, Anne Madroszyk, Alan Tseng, Wisdom Akingbemi, Jaklin Gukasyan, John Madrigal, James Carroll, Zorawar Noor, Amy Lauren Cummings, Daniel Olive, Edward Garon
- Abstract
Loading... -
+
P1.04-34 - Efficacy and Safety of First-Line Pembrolizumab Monotherapy in Elderly Patients (Aged ≥ 75 years) with Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Tomohide Sugiyama | Author(s): Hisao Imai, Satoshi Wasamoto, Ou Yamaguchi, Kensuke Suzuki, Junji Uchino, Hiroyuki Minemura, Takashi Osaki, Takashi Ishii, Yukihiko Umeda, Hirokazu Taniguchi, Takashi Kasai, Koichi Minato, Kyoichi Kaira
- Abstract
Loading... -
+
P1.04-35 - Identification and Characterization of a Unique KLRG1-Expressing Subset of CD4+FOXP3+ Tregs in Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Dennis Adeegbe | Author(s): Jonathan Semidey-Hurtado, David Noyes, Andrew Schultz
- Abstract
Loading... -
+
P1.04-36 - An in Vivo Inflammatory Loop Potentiates KRAS Blockade
09:45 - 09:45 | Presenter: Kristina Anna Maria Arendt | Author(s): Giannoula Ntaliarda, Vasileios Armenis, Georgios Stathopoulos
- Abstract
Loading... -
+
P1.04-37 - Dioscin Elicits Anti-Tumor Immunity by Inhibiting Macrophages M2 Polarization via JNK and STAT3 Pathways in Lung Cancer
09:45 - 09:45 | Presenter: Yinan Yao | Author(s): Luyun Cui, Jiani Ye, Jianying Zhou
- Abstract
Loading... -
+
P1.04-38 - Efficacy and Safety of Immunotherapy in Elderly Patients with Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Giuseppe Lo Russo | Author(s): Giulia Galli, Alessandro De Toma, Filippo Pagani, Giovanni Randon, Benedetta Trevisan, Arsela Prelaj, Roberto Ferrara, Claudia Proto, Diego Signorelli, Monica Ganzinelli, Nicoletta Zilembo, Filippo Guglielmo Maria De Braud, Marina Chiara Garassino
- Abstract
Loading... -
+
P1.04-39 - Molecular Characteristics, Immunophenotype, and Immune Checkpoint Inhibitor Response in BRAF Non-V600 Mutant Lung Cancers
09:45 - 09:45 | Presenter: Michael Offin | Author(s): Terry Pak, Sebastian Mondaca, Joseph Montecalvo, Natasha Rekhtman, Darragh F Halpenny, Stephanie L Wu, Mark G Kris, Paul Paik, Gregory J Riely, Charles M Rudin, David M. Hyman, Matthew Hellmann, Alexander Drilon, Josiah D Land, Larry Buie, Piro Lito, Rona Yaeger, Dazhi Liu, Bob T Li
- Abstract
Loading... -
+
P1.04-40 - Serum Perforin Levels During the First Cycle of Anti-PD-1 Antibody Therapies in Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Takayo Ota | Author(s): Tomoya Fukui, Yoshiro Nakahara, Takayuki Takeda, Junji Uchino, Takako Mouri, Keita Kudo, Saki Nakajima, Tomohiro Suzumura, Takafumi Okabe, Hidetoshi Hayashi, Nozomi Miyatake, Yusuke Nakano, Masaaki Terashima, Yoshikazu Hasegawa, Hiroshi Tsukuda, Kaoru Matsui, Noriyuki Masuda, Masahiro Fukuoka
- Abstract
Loading... -
+
P1.04-41 - Immunotherapy Concomitant to Radiotherapy: A Multicentric Retrospective Study on 179 Patients with Advanced Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Alessio Bruni | Author(s): Patrizia Ciammella, Lorenzo Falcinelli, Carlo Greco, Niccolo' Giaj Levra, Davide Franceschini, Marco Perna, Luca Frassinelli, Alessandra Taddeo, Virginia Maragna, Marco Lorenzo Bonu', Simona Marani, roberto Rossi, Maria Taraborrelli, Elisa D'Angelo, Federica Bertolini, Paolo Borghetti, Vieri Scotti
- Abstract
Loading... -
+
P1.04-42 - Tumor Microenvironment Is Associated with Efficacy of PD-1/PD-L1 Inhibitors in Patients with Primary Pulmonary Lymphoepithelioma-Like Cancer
09:45 - 09:45 | Presenter: Xu-Chao Zhang | Author(s): Kai Yin, Zhi Xie, Zhi Yi Lv, Jin-Ji Yang, Xue-Ning Yang, Qing Zhou, Wen-Zhao Zhong, Lin-Lin Li, Hui-Bo Feng, Wei-Bang Guo, Dan-Xia Lu, Yu Chen, Wen-Qing Yan, Yi-Long Wu
- Abstract
Loading... -
+
P1.04-43 - PD-RAD: A Translational Study Investigating PD-L1 Expression After Radiotherapy for Non-Small Cell Lung Cancer - Trial in Progress
09:45 - 09:45 | Presenter: Tiana Kordbacheh | Author(s): Eleanor Cheadle, Clara Chan, Catherine Trigwell, Emmie Taylor, Crispin Hiley, Kevin Franks, Christy Ralph, Matthew Hatton, Anshuman Chaturvedi, Philip Crosbie, Martin David Forster, Caroline Dive, Corinne Faivre-Finn, Timothy Illidge
- Abstract
Loading... -
+
P1.04-44 - Radiomics for Predicting Response to First-Line Anti-PD1 Therapy in Advanced NSCLC
09:45 - 09:45 | Presenter: Christoph Jakob Ackermann | Author(s): Isabella Fornacon-Wood, Rebecca Tay, Prakash Manoharan, Gareth Price, Colin Lindsay, Corinne Faivre-Finn, Fiona Blackhall, David Catharina Petrus Cobben
- Abstract
Loading... -
+
P1.04-45 - Immune-Oncology Gene Expression Profiles Allow Lung Cancer Patients’ Stratification and Identification of Responders to Immunotherapy
09:45 - 09:45 | Presenter: Fabrizio Tabbò | Author(s): Laura Annaratone, Alberto Nocifora, Chiara Vignale, Simona Carnio, Jasna Metovic, Francesca Veneziano, Simona Scodes, Alessandro Russo, Tindara Franchina, Claudio Sini, Simona Coco, Pietro Garlatti, Scotti Vieri, Vincenzo Adamo, Simona Boccardo, Francesco Grossi, Federico Cappuzzo, MAURO GIULIO PAPOTTI, luisella Righi, francesco Passiglia, Silvia Novello
- Abstract
Loading... -
+
P1.04-46 - PD-1 Inhibitor Plus Chemotherapy as 2nd/Subsequent Line Setting Demonstrate Superior Efficacy Over PD-1 Inhibitor Alone in Pts of Advanced NSCLC
09:45 - 09:45 | Presenter: Shengxiang Ren | Author(s): Yiwei Liu, Fei Zhou, Tao Jiang, Chunxia Su, Xiaoxia Chen, Caicun Zhou
- Abstract
Loading... -
+
P1.04-47 - Tumor Mutation Burden Through Hybrid Capture – Circulating Tumor DNA May Predict Response to Immunotherapy in NSCLC
09:45 - 09:45 | Presenter: Roxana Denisa Grinberg | Author(s): Laila C. Roisman, Smadar Geva, Martina I. Lefterova, Katie Quinn, Lior Soussan Gutman, Addie Dvir, Roi Yair, Richard B Lanman, Divya Mehta, Lesli A. Kiedrowski, Luis Raez, Nir Peled
- Abstract
Loading... -
+
P1.04-48 - Prediction of Tumor Doubling Time of Lung Adenocarcinoma Using Radiomics Margin Characteristics
09:45 - 09:45 | Presenter: Hyun Jung Yoon | Author(s): Hyunjin Park, Ho Yun Lee, Insuk Sohn, Joonghyun Ahn, Seung-hak Lee
- Abstract
Loading... -
+
P1.04-49 - Quantitative Computed Tomography (CT) Based Texture Analysis (QTA) Might Identify Responders to Immunotherapy in Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Zsolt Megyesfalvi | Author(s): Csilla Kugler, Andrea Fülöp, Szabolcs Gergely, Botond Megyesfalvi, Anna Kerpel-Fronius, Balázs Döme, Ronald L. Korn, Glen J. Weiss, Zoltán Lohinai
- Abstract
Loading... -
+
P1.04-50 - Real World Efficacy of Pembrolizumab of as a 1st Line Treatment in Metastatic Non-Small Cell Lung Cancer with PD-L1 High Expression
09:45 - 09:45 | Presenter: Kazuo Kasahara | Author(s): Takashi Sone, Kouichi Nishi, Kazuhiko Shibata, Tomoyuki Araya, Hiroki Shirasaki, Taro Yoneda, Kazumasa Kase, Shingo Nishikawa, Hideharu Kimura, Yuichi Tambo
- Abstract
Loading... -
+
P1.04-51 - Treatment with Immune Checkpoint Inhibitors for Advanced NSCLC in Elderly and Frail Patients. A Real-Life Experience
09:45 - 09:45 | Presenter: Karen Fuglsang Junker | Author(s): Gitte Fredberg Persson, Jon Alexander Lykkegaard Andersen, Jens Benn Sørensen, Seppo Langer, Mette Pøhl
- Abstract
Loading... -
+
P1.04-52 - The Role of Blood Biomarkers in Radiation Therapy for Thoracic Malignancies
09:45 - 09:45 | Presenter: Eleni Gkika | Author(s): Sonja Adebahr, Tanja Schimek-Jasch, Gabriele Niedermann, Ursula Nestle, Anca-Ligia Grosu, Dan Gabriel Duda
- Abstract
Loading... -
+
P1.04-53 - A High PD-L1 Expression in Non-Small Cell Lung Cancer Correlates with Expression of SPOP and CD8 Tumor-Infiltrating Lymphocytes
09:45 - 09:45 | Presenter: Masaaki Inoue | Author(s): Junichi Yoshida, Soichi Oka, Yohei Honda, Yasuhiro Chikaishi, Daisei Yasuda
- Abstract
Loading... -
+
P1.04-54 - Inter-Tumor Heterogeneity of PD-L1 Expressions in Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Yuichi Saito | Author(s): Sho Horiuchi, HIROAKI Morooka, TAKAYUKI Ibi, NOBUMASA Takahashi, TOMOHIKO Ikeya, EISHIN Hoshi, YOSHIHIKO Shimizu
- Abstract
Loading... -
+
P1.04-55 - Comparison of PD-L1 Expression Status Between Pure-Solid Versus Part-Solid Tumors in Lung Adenocarcinomas
09:45 - 09:45 | Presenter: Kenichi Suda | Author(s): Shigeki Shimizu, Masaki Shimoji, Katsuaki Sato, Shuta Ohara, Toshio Fujino, Masaya Nishino, Takamasa Koga, Akira Hamada, Kenji Tomizawa, Toshiki Takemoto, Junichi Soh, Tetsuya Mitsudomi
- Abstract
Loading... -
+
P1.04-56 - Landscape of Tumor Mutational Burden in Indian NSCLC Patients
09:45 - 09:45 | Presenter: Prashant Mehta | Author(s): Boman Dhabhar, Amit Bhatt, Palanki Satya Dattatreya, Anish Maru, Rajeev Vijayakumar, Vashishth Maniar, maheboob Basade, Kaushal Patel, Shirish S Alurkar, Charu Bahl, Seema Todur
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.04-58 - Uncovering the Tumor Microenvironment of KRAS-Driven Lung Adenocarcinoma: The Link Between Th17 Signaling and B Cell
09:45 - 09:45 | Presenter: Stefania Tommasi | Author(s): Simona De Summa, Daniela Petriella, Rosanna Lacalamita, Domenico Galetta, Michele Montrone, Annamaria Catino, Pamela Pizzutilo, Maria Antonietta Botticella, Francesco Alfredo Zito, Milena Zambetti, Antonia Zonno, Rosamaria Pinto
- Abstract
Loading... -
+
P1.04-59 - Modified Glasgow Prognostic Score Predict Survival Among Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
09:45 - 09:45 | Presenter: Cláudia Freitas | Author(s): Nuno Tavares, Maria Jacob, Denisa Mendonça, Pedro Oliveira, David Araújo, Hélder Novais-Bastos, Gabriela Fernandes, Adriana Magalhães, Henrique Queiroga, Venceslau Hespanhol
- Abstract
Loading... -
+
P1.04-60 - Impact of Metastatic Location on Survival in Stage-IV Non-Small Cell Lung Cancer (NSCLC) Treated with Immunotherapy
09:45 - 09:45 | Presenter: Sweta Jonnalagadda | Author(s): abdul rafeh Naqash, Shravanti Macherla, Shanker Polsani, Mahvish Muzaffar, Cynthia L Cherry, Nagla Abdel Karim, Paul Raymond Walker
- Abstract
Loading... -
+
P1.04-61 - Neutrophil-Lymphocyte Ratio: A Predictive Biomarker of Immunotherapy in Lung Cancer?
09:45 - 09:45 | Presenter: Nuno China | Author(s): Maria Aurora Mendes, Daniel Oliveira Reis, Sérgio Campainha, Margarida Dias, Ana Barroso
- Abstract
Loading... -
+
P1.04-62 - Nomogram Based on Multivariable Regression Model Estimates the Overall Survival of Nivolumab for Previously Treated Advanced NSCLC
09:45 - 09:45 | Presenter: Motohiro Tamiya | Author(s): Akihiro Tamiya, Hirofumi Go, Takako Inoue, Madoka Kimura, Kei Kunimasa, Kenji Nakahama, Yoshihiko Taniguchi, Takayuki Shiroyama, Shun-ichi Isa, Kazumi Nishino, Toru Kumagai, Hidekazu Suzuki, Shinji Atagi, Tomonori Hirashima, Ayumi Shintani, Fumio Imamura
- Abstract
Loading... -
+
P1.04-63 - Correlation of Mutations in TP53, CDKN2A and PIK3CA with VISTA Expression in Pleomorphic Lung Carcinoma
09:45 - 09:45 | Presenter: Adam Januszewski | Author(s): Yu Zhi Zhang, Cecilia Brambilla, Wei-Chin Chang, Ute Laggner, Alex Bowman, Toyin Adefila-Ideozu, Igor Vivanco, William O.C Cookson, Miriam F Moffatt, Andrew G Nicholson, Sanjay Popat, Anne M Bowcock
- Abstract
Loading... -
+
P1.04-64 - The Opposite Role of PD-L1 Expression in EGFR Mutant Lung Cancer Treated with PD-1 Inhibitor Before and After EGFR TKI: Pilot Study
09:45 - 09:45 | Presenter: Hyung Soon Park | Author(s): Sung Shim Cho, Ho Jung An, Jinyoung Yoo, Byoung Yong Shim, Sung Kyoung Kim, Deog Gon Cho, Sung Whan Kim, Jeong Min Ko, Young Ha Park, Chi Hong Kim
- Abstract
Loading... -
+
P1.04-65 - Microenvironment-Derived ADAM28 Impacts the Onset of Lung Cancer
09:45 - 09:45 | Presenter: Céline Hubeau | Author(s): Catherine Gerard, Oriane Carnet, Markus Moser, Reinhard Fässler, Agnès Noël, Natacha Rocks, Didier Cataldo
- Abstract
Loading... -
+
P1.04-66 - The Percentage of PD-L1 Besides 50% Positivity Predicts Objective Response to Pembrolizumab in Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Anello Marcello Poma | Author(s): Giulia Pasquini, Rossella Bruno, Greta Alì, Agnese Proietti, Irene Pecora, Lacopo Petrini, Enrico Vasile, Antonio Chella, Gabriella Fontanini
- Abstract
Loading... -
+
P1.04-67 - First-Line Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer (NSCLC) – A Network Meta-Analysis by PD-L1
09:45 - 09:45 | Presenter: Gilberto Lopes | Author(s): Pui San Tan, Pedro Nazareth Aguiar Junior, Muhammad Husnain, Benjamin Haaland
- Abstract
Loading... -
+
P1.04-68 - Liver Metastases Predicts Poorer Prognosis in Advanced NSCLC Patients Who Receiving Nivolumab Monotherapy
09:45 - 09:45 | Presenter: Guowei Zhang | Author(s): Ruirui Cheng, Huijuan Wang, Zhiyong Ma
- Abstract
Loading... -
+
P1.04-69 - Modelling the Immunosuppressive Difference of SBRT and CRT by Simulating the Dose to Circulating Lymphocytes in Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Haihua Yang | Author(s): Yichao Shen, Yinnan Meng, Xingni Tang, Pinjun Gu, Changhui Yu, Wei Wang, Feng-Ming Spring Kong
- Abstract
Loading... -
+
P1.04-70 - Application of Tumor Kinetics for Evaluation of Hyperprogression in Immune Checkpoint Inhibitor Treatment for Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Cheol-Kyu Park | Author(s): Min-Seok Kim, In-Jae Oh, Young-Chul Kim
- Abstract
Loading... -
+
P1.04-71 - Tumor Burden Is Not Associated with Efficacy of Immune Checkpoint Inhibitors in Advanced Lung Cancer
09:45 - 09:45 | Presenter: David E. Gerber | Author(s): Vinita Popat, Rong Lu, Jessica Saltarski, Yvonne Gloria-Mccutchen1, Farjana Fattah, Jason Park, Yang Xie
- Abstract
Loading... -
+
P1.04-72 - Tumor Mutational Burden as a Potential Predictive Biomarker of Response to PD-1/PD-L1 Blockade in Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Hyojin Kim | Author(s): Hyun Jung Kwon Kwon, Eun Sun Kim Kim, Yeon Bi Han, Jeonghyo Lee, Se Hyun Kim, Yu Jung Kim, Jong-Seok Lee, Jin-Haeng Chung
- Abstract
Loading... -
+
P1.04-73 - Small Cell Transformation of Non-Small Cell Lung Cancer (NSCLC) on Immune Checkpoint Inhibitors: Case Report and Literature Review
09:45 - 09:45 | Presenter: Kartik Sehgal | Author(s): Andreas Varkaris, Paul A. Vanderlaan, Deepa Rangachari, Daniel B Costa
- Abstract
Loading... -
+
P1.04-74 - Characteristics of T Cell Receptor Repertoire of Lung Cancer Patients
09:45 - 09:45 | Presenter: Naixin Liang | Author(s): Huaxia Yang, Ziqi Jia, Xiaoying Yang, Pancheng Wu, Yanyu Wang, Yadong Wang, Zhongxing Bing, Lei Cao, Zhili Cao, Dejian Gu, Rongrong Chen, Xuefeng Xia, Shanqing Li
- Abstract
Loading... -
+
P1.04-75 - Immune-Related Adverse Events and the Neutrophil to Lymphocyte Ratio as Predictors of Clinical Response to Immunotherapy
09:45 - 09:45 | Presenter: Luis Raez | Author(s): Hermán Wesley Powery, Donalle Devon Johnson, Imani Pelt, Katerine Dumais, Gelenis Domingo, Brian Hunis, Paola Izquierdo, Christopher C. Smith
- Abstract
Loading... -
+
P1.04-76 - Predictive Factors of Early Therapeutic Failure to Immunotherapy in Patients with Metastatic NSCLC
09:45 - 09:45 | Presenter: Victor Aurelio Ramos Sousa | Author(s): Victor Hugo Fonseca De Jesus, Thiago Pimentel Muniz, Malu Viter Da Rosa Barbosa, Helano C. Freitas, Vladmir Cláudio Cordeiro De Lima
- Abstract
Loading... -
+
P1.04-77 - Efficacy of Anti-PD-1/L1 Therapy for Advanced Non-Small Cell Lung Cancer with Preexisting Autoimmune Markers
09:45 - 09:45 | Presenter: Takako Inoue | Author(s): Madoka Kimura, Kei Kunimasa, Motohiro Tamiya, Hanako Kuhara, Kazumi Nishino, Terutaka Hino, Toru Kumagai
- Abstract
Loading... -
+
P1.04-78 - Efficacy of Checkpoint Inhibitors in Combination with Chemotherapy for First-Line Treatment of Advanced Non-Squamous NSCLC
09:45 - 09:45 | Presenter: Kyaw Zin Thein | Author(s): Nusrat Jahan, Anita Sultan, Sriman Swarup, Aung Myint Tun, Rachana Yendala, Somedeb Ball, Pwint Phyu Hlaing, Thura Win Htut, Shabnam Rehman, Nicholas D’cunha, Fred Hardwicke, Lukman Tijani, Sanjay Awasthi
- Abstract
Loading... -
+
P1.04-79 - CD73 Expression in Lung Adenocarcinomas and Immunological and Molecular Associations
09:45 - 09:45 | Presenter: Carmen Behrens | Author(s): Pedro Rocha, Ruth Salazar, Jose Solorzano, Jiexin Zhang, Barbara Mino, Edwin Parra, Debora Ledesma, Humam Kadara, Jianjun Zhang, Ara A Vaporciyan, David Rice, Neda Kalhor, Cesar Moran, Don Lynn Gibbons, Annikka Weissferdt, Boris Sepesi, Ignacio Wistuba, Luisa Maren Solis
- Abstract
Loading... -
+
P1.04-80 - Immunotherapy-Related Thrombosis: Considerations and Associated Factors in Non-Small Cell Lung Cancer (NSCLC) Patients
09:45 - 09:45 | Presenter: Oscar Gerardo Arrieta | Author(s): Andrés Felipe Cardona, Alejandro Ruiz-Patiño, Zyanya Lucia Zatarain Barrón, Luis Leonardo Rojas, Luis Corrales, Claudio Martin, Feliciano Barrón, Carolina Sotelo, July Rodriguez, Luisa Ricaurte, Jenny Ávila, Melissa Bravo, Diana Mayorga, Pilar Archila, Helano C. Freitas, Vladmir Cláudio Cordeiro De Lima, Luis Mas, Jorge Otero, Hernán Carranza, Carlos Vargas, Rafael Rosell
- Abstract
Loading... -
+
P1.04-81 - Characterization of Hispanic Patients Who Experienced Hyperprogression During Treatment for Advanced NSCLC with Immunotherapy
09:45 - 09:45 | Presenter: Oscar Gerardo Arrieta | Author(s): Alejandro Ruiz-Patiño, Andrés Felipe Cardona, Claudio Martin, Luis Raez, Zyanya Lucia Zatarain Barrón, Feliciano Barrón, Luisa Ricaurte, María A. Bravo-Garzón, Luis Mas, Luis Corrales, Luis Leonardo Rojas, Lorena Lupinacci, Florencia Perazzo, Carlos Bas, Omar Carranza, Carmen Puparelli, Manglio Miguel Rizzo, Rossana Ruiz, Christian Rolfo, Pilar Archila, July Rodriguez, Carolina Sotelo, Carlos Vargas, Hernán Carranza, Jorge Otero, Luis Eduardo Pino, Carlos Ortiz, Paola Laguado, Rafael Rosell
- Abstract
Loading... -
+
P1.04-82 - Toxicity as a Clinical Marker for Efficacy of Immunotherapy in NSCLC: A Multicentric Experience from Argentina
09:45 - 09:45 | Presenter: Maria Florencia Rizzi | Author(s): Manglio Miguel Rizzo, Nicolás Minatta, Gonzalo Recondo Jr., Martin Naveira, Lorena Lupinacci, Alejandro Daniel Kuzminin, Maria Victoria Faura, Aldo Agustin Perfetti, Susana Noemi Sena, Maria Virginia Bluthgen
- Abstract
Loading... -
+
P1.04-83 - Combining Immune Gene Polymorphism and Immune Profile Predicts Brain Metastases and Death in a Brazilian Cohort of Non-Small Cell Lung Carcinoma
09:45 - 09:45 | Presenter: Vera Luiza Capelozzi | Author(s): Juliana Machado-Rugolo, Alexandre Fabro, Cláudia Aparecida Rainho, Cecilia Farhat, Vanessa Karen De Sa, Ana Carolina Scintini Herbst, Vladmir Cláudio Cordeiro De Lima, Edwin Parra
- Abstract
Loading... -
+
P1.04-84 - MiR-195 Restrains Lung Adenocarcinoma via Regulating CD4+ T Cell Activation Through CCDC88C/Wnt Signaling Pathway
09:45 - 09:45 | Presenter: Conghua Xie | Author(s): Cheng Yuan
- Abstract
Loading...
-
+
P1.06 - Mesothelioma
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Mesothelioma
-
+
P1.06-01 - Combining Immunoprofile, Immunogenic Collagen and Mismatch Repair Proteins Predicts Risk of Death and Target Therapy in Malignant Mesothelioma
09:45 - 09:45 | Presenter: Juliana Machado-Rugolo | Author(s): Marcelo Balancin, Vanessa Martins, Jurandir Miranda, Aline Assato, Neila Souza, Ana Paula Velosa, Roberto Falzoni, Alexandre Ab´saber, Walcy Teodoro, Vera Luiza Capelozzi
- Abstract
Loading... -
+
P1.06-02 - National Trends in Outcomes in Patients with Malignant Pleural Mesothelioma
09:45 - 09:45 | Presenter: Kaushal Parikh | Author(s): Urshila Durani, Shealeigh Funni, Jonathan Inselman, Konstantinos Leventakos, Aaron S. Mansfield
- Abstract
Loading... -
+
P1.06-03 - Selective Depletion of Foxp3+ Regulatory T Cells After Local Radiotherapy Induces Abscopal Effects in Murine Malignant Mesothelioma
09:45 - 09:45 | Presenter: Mikihiro Kohno | Author(s): Junichi Murakami, Licun Wu, Mei-Lin Chan, Zhihong Yun, Marc De Perrot
- Abstract
Loading... -
+
P1.06-04 - Deep Learning-Based Segmentation of Mesothelioma on CT Scans: Application to Patient Scans Exhibiting Pleural Effusion
09:45 - 09:45 | Presenter: Samuel G Armato | Author(s): Eyjolfur Gudmundsson, Christopher M Straus, Feng Li, Hedy Lee Kindler
- Abstract
Loading... -
+
P1.06-05 - Clinical Features and Outcomes of Recurrence After Pleurectomy/Decortication for Malignant Pleural Mesothelioma
09:45 - 09:45 | Presenter: Akifumi Nakamura | Author(s): Masaki Hashimoto, Ayumi Kuroda, Toru Nakamichi, Seiji Matsumoto, Nobuyuki Kondo, Takashi Kijima, Seiki Hasegawa
- Abstract
Loading... -
+
P1.06-06 - EORTC 1205: Randomized Study of Pleurectomy/Decortication (P/D) Preceded or Followed by Chemotherapy in Malignant Pleural Mesothelioma
09:45 - 09:45 | Presenter: Jan P Van Meerbeeck | Author(s): Paul Van Schil, Veerle Surmont, Rabab Gaafar, Robin Cornelissen, Baktiar Hasan, Alessia Pochesci, Alex WPM Maat, Paul Baas, Frank Vermassen
- Abstract
Loading... -
+
P1.06-07 - Targeting Photo-Therapy for Malignant Pleural Mesothelioma; Near Infrared Photoimmunotherapy Targeting Podoplanin
09:45 - 09:45 | Presenter: Yuko Nishinaga | Author(s): Yoshitaka Isobe, Hirotoshi Yasui, Kazuomi Takahashi, Shunichi Taki, Toshinori Matsui, Kazuhide Sato, Yoshinori Hasegawa, Yukinari Kato
- Abstract
Loading... -
+
P1.06-08 - WDPM-Like but Not Cribriform as Secondary Growth Patterns Modify Survival in Epithelioid Malignant Pleural Mesothelioma
09:45 - 09:45 | Presenter: Yu Zhi Zhang | Author(s): Cecilia Brambilla, Alexandra Rice, Jan Lukas Robertus, Simon Jordan, Eric Lim, loic Lang-Lazdunski, Sanjay Popat, Aliya Husain, Miriam F Moffatt, William O.C Cookson, Andrew G Nicholson
- Abstract
Loading... -
+
P1.06-09 - Prophylactic Irradiation of Tracts in Patients with Malignant Pleural Mesothelioma: A Systematic Review and Meta-Analysis
09:45 - 09:45 | Presenter: Yu Yang Soon | Author(s): Balamurugan Vellayappan, Cheng Nang Leong, Wee Yao Koh, Jeremy Chee Seong Tey, Ivan Weng Keong Tham
- Abstract
Loading... -
+
P1.06-10 - 18F-FDG PET/CT in Malignant Pleural Mesothelioma: Diagnostic/Prognostic Performance and Correlation with Pathological Results
09:45 - 09:45 | Presenter: Filippo Lococo | Author(s): Ottavio Rena, Federica Torricelli, Angelina Filice, Teresa Di Stefano, Cristian Rapicetta, Chiara Coruzzi, Renzo Boldorini, Alessia Ciarrocchi, Annibale Versari, Massimiliano Paci
- Abstract
Loading... -
+
P1.06-11 - Overlapping Immunophenotypes Between Mesothelioma and Angiosarcoma: Usefulness of Claudin-5 in the Differential Diagnosis
09:45 - 09:45 | Presenter: Yasuhiro Nakashima | Author(s): Kentaro Inamura, Hironori Ninomiya, Susumu Kirimura, Masashi Kobayashi, Kenichi Okubo, Yuichi Ishikawa
- Abstract
Loading... -
+
P1.06-12 - Defects in Homologous Recombination Repair Indicates Susceptibility for Olaparib Treatment in Malignant Pleural Mesothelioma
09:45 - 09:45 | Presenter: Sabrina Borchert | Author(s): Michael Wessolly, Jan Schmeller, Elena Mairinger, Jens Kollmeier, Thomas Hager, Thomas Mairinger, Thomas Herold, Daniel Christian Christoph, Robert Fred Henry Walter, Wilfried Ernst Erich Eberhardt, Till Plönes, Jeremias Wohlschlaeger, Clemens Aigner, Kurt Werner Schmid, Fabian Dominik Mairinger
- Abstract
Loading... -
+
P1.06-13 - Treatment Patterns and Outcomes in Advanced Malignant Pleural Mesothelioma: Surveillance, Epidemiology, and End Results Data
09:45 - 09:45 | Presenter: Melinda Daumont | Author(s): Esmond D Nwokeji, Deborah P Lubeck, Michelle Gleeson, John Penrod, Mark Danese
- Abstract
Loading... -
+
P1.06-14 - Posterior Intercostal Lymph Node Positivity as a Prognostic Indicator of Overall Survival in Resectable Malignant Pleural Mesothelioma
09:45 - 09:45 | Presenter: Aneesha Hossain | Author(s): Jingjing Chen, Aaron Iddings, srilakshmi Bathini, Tamara Khashab, Melissa Jane Culligan, Pranshu Mohindra, Katherine Ann Scilla, Christian Rolfo, Joseph Friedberg
- Abstract
Loading... -
+
P1.06-15 - Safety of Irradiation Combined with Intracavitary Cisplatin-Fibrin After Lung-Sparing Surgery in a Rat Model of Mesothelioma
09:45 - 09:45 | Presenter: Isabelle Opitz | Author(s): Olivia Lauk, Michaela B Kirschner, Mayura Meerang, Katarzyna Furrer, Ivo Grgic, Vanessa Orlowski, Fabienne Tschanz, Martin Pruschy
- Abstract
Loading... -
+
P1.06-16 - Molecular Signature in Malignant Pleural Mesothelioma (MPM). Preliminary Data of Rames Study
09:45 - 09:45 | Presenter: Maria Pagano | Author(s): francesca Zanelli, roberta Gnoni, candida Bonelli, marcello Tiseo, giulia Pasello, federica Grosso, Marina Chiara Garassino, Hector Soto Parra, Paolo Zucali, Ceresoli Giovanni Luca, Federica Torricelli, Alessia Ciarrocchi, Mario Larocca, Manolo D'Arcangelo, Carmine Pinto
- Abstract
Loading... -
+
P1.06-17 - Tumor Treating Fields (150 kHz) Combined with Cisplatin or Pemetrexed Inhibits Mesothelioma Cells in Vitro and in Vivo
09:45 - 09:45 | Presenter: Uri Weinberg | Author(s): Mijal Munster, Karnit Gotlib, Rosa S Schneiderman, Yaara Porat, Tali Voloshin, Shiri Davidi, Anna Shteingauz, Noa Kaynan, Einav Zeevi, Moshe Giladi, Eilon D Kirson, Adrian Kinzel, Yoram Palti
- Abstract
Loading... -
+
P1.06-18 - MicroRNA Expression Is Linked to Response of Malignant Pleural Mesothelioma to Cisplatin-Pemetrexed Chemotherapy
09:45 - 09:45 | Presenter: Michaela B Kirschner | Author(s): Yan Zhang, Vanessa Orlowski, Bart Vrugt, Martina Friess, Walter Weder, Isabelle Opitz
- Abstract
Loading... -
+
P1.06-19 - Regional Mesothelioma Multidisciplinary Team Meetings: Perspectives from a UK Cardiothoracic Tertiary Centre
09:45 - 09:45 | Presenter: Kate Slaven
- Abstract
Loading... -
+
P1.06-20 - Malignant Pleural Mesothelioma: Survival Meta-Analysis from 15 Years of a Standard Systemic Therapy
09:45 - 09:45 | Presenter: Joseph Friedberg | Author(s): Melissa Jane Culligan
- Abstract
Loading... -
+
P1.06-21 - Safety Meta-Analysis of Clinical Trials Delivering Tumor Treating Fields to the Upper Torso
09:45 - 09:45 | Presenter: Uri Weinberg | Author(s): Giovanni L. Ceresoli, Miklos Pless
- Abstract
Loading... -
+
P1.06-22 - Pathologic and Imaging Response Correlations in Patients Treated with Neoadjuvant Chemotherapy for Mesothelioma
09:45 - 09:45 | Presenter: Muneeb Rehman | Author(s): Anja C. Roden, Aaron S. Mansfield
- Abstract
Loading...
-
+
P1.07 - Nursing and Allied Professionals
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Nursing and Allied Professionals
-
+
P1.07-01 - Lung Cancer Support Groups: Still Relevant in a Digital World?
09:45 - 09:45 | Presenter: Maureen Rigney | Author(s): Kevin Stein
- Abstract
Loading... -
+
P1.07-02 - Implementation of a Health and Wellbeing Programme in Conjunction with Pulmonary Rehabiliatation
09:45 - 09:45 | Presenter: Josianne Roberts | Author(s): Kate Kontou, Suzanne Davies, Traci Gray
- Abstract
Loading... -
+
P1.07-03 - Improving Non-Oncology Provider Knowledge of Unique Immunotherapy Adverse Events
09:45 - 09:45 | Presenter: Enza Esposito Nguyen
- Abstract
Loading... -
+
P1.07-04 - Early Lung Cancer Team Intervention in Emergency Admissions
09:45 - 09:45 | Presenter: Joanne Dunbar | Author(s): Martin Ledson, Andrea McIver, Nicola Maddock, Sophie Sanders, Colin Smyth, Martin Walshaw
- Abstract
Loading... -
+
P1.07-05 - Developing a Nursing Triage Tool to Assess Patient Support Needs Through Treatment for Lung Cancer
09:45 - 09:45 | Presenter: Jackie Fenemore | Author(s): Hilary Neal, Marie Eaton, Delyth McEntee, Emma Halkyard, Layla Bostock
- Abstract
Loading... -
+
P1.07-06 - Use of the Nutritional Risk Index as Screening for Malnutrition in Patients with Lung Cancer
09:45 - 09:45 | Presenter: Imanuely Borchardt Gonçalves | Author(s): Amanda Maria Ferreira, Gisele Fraga Moreira, Juliana Abreu Vasconcellos, Tatiane Montella, Wilza Ferreira Peres, Carlos Gil Ferreira
- Abstract
Loading... -
+
P1.07-07 - An Interdisciplinary Collaborative Approach to Discharge Readiness on a Thoracic Surgery Specialty Unit
09:45 - 09:45 | Presenter: Sorah Levy | Author(s): Christine Hahner, Francesca Carhart
- Abstract
Loading... -
+
P1.07-08 - Screening for Fear of Cancer Recurrence in Operable Lung Cancer Patients-Scale Validation and Current Status
09:45 - 09:45 | Presenter: Yeur-Hur Lai | Author(s): Jin-Shing Chen, Yun-Hsiang Lee, I-Chin Huang
- Abstract
Loading... -
+
P1.07-09 - Implementation of a Nursing Program for Cancer Patients Treated with Immunotherapy by an Immunotherapy Nurse Specialist
09:45 - 09:45 | Presenter: Jorgina Serra | Author(s): Margarita Majem, Ivana G. Sullivan, Mariona Riudavets, Georgia Anguera, Andrés Barba, Iria González, Núria Guàrdia
- Abstract
Loading... -
+
P1.07-10 - Investigation on Nutritional Status and Quality of Life of Patients with Lung Cancer Treated by Radiotherapy in Different Sexes
09:45 - 09:45 | Presenter: Shu-Ping Xie | Author(s): Qiong-Yao Jiang, Si-Yu Yang, Xi Yang, Yu-Yan Gu, Jia-Qin Shen
- Abstract
Loading... -
+
P1.07-11 - An Evaluation of the Patient’s Experience and Expectations During the Implementation of NHS England, National Optimal Lung Cancer Pathway
09:45 - 09:45 | Presenter: Karen Jane Clayton | Author(s): Andrea McIver, A Bougler, C Buckle, C Butler, J Draffen, S Earl, Y Jeffs, S Jones, C Jordan, J Morley, H Neal, S Newbold, J Roberts, P Rose, p Shepherd, B Smith
- Abstract
Loading... -
+
P1.07-12 - Essential Psychosocial Requirements for Quality Lung Cancer Care
09:45 - 09:45 | Presenter: Csaba Laszlo Degi
- Abstract
Loading... -
+
P1.07-13 - The Application of Intracavitary Electrocardiogram in the Femoral Vein Catheter Tip Location in Chemotherapy Patients with Lung Cancer
09:45 - 09:45 | Presenter: Jinghui Zhang
- Abstract
Loading... -
+
P1.07-14 - Frailty and Treatment Decision Making in Older People with Lung Cancer
09:45 - 09:45 | Presenter: Angela Mary Tod | Author(s): Julie Skilbeck, Clare Warnock, Nancy Ali, Janet Ulman
- Abstract
Loading... -
+
P1.07-15 - Screening for Long Term Ototoxicity in Lung and Upper Aerodigestive Cancer Survivors Treated with Platinum Chemotherapy
09:45 - 09:45 | Presenter: Simranjit Kooner | Author(s): Geoffrey Liu, Katrina Hueniken, Suheon Lee, Jennifer Harris, Catherine De Guia, Edith Anokye-Yeboah, Pansy Chow, Priya Bapat, Wei Xu, Doris Howell, Iryna Tymoshyk, Anne Embleton
- Abstract
Loading... -
+
P1.07-16 - Training Program for University Nursing Students to Reduce Lung Cancer Patient Emotional Distress
09:45 - 09:45 | Presenter: Somaya El sayed Abouabdou
- Abstract
Loading... -
+
P1.07-17 - Transfer of Care: Effective Communication to Promote Improved Patient Experience
09:45 - 09:45 | Presenter: Nazanin Nouriany | Author(s): Taylor Cline, Jared Cullis
- Abstract
Loading... -
+
P1.07-18 - The Effect of Lung Cancer on Patient Sexual Functioning: Nursing View
09:45 - 09:45 | Presenter: Somaya El sayed Abouabdou
- Abstract
Loading... -
+
P1.07-19 - Palliative Care Social Workers Multi-Dimensional Roles: A Namibian Perspective
09:45 - 09:45 | Presenter: Rachel J Johanna Freeman
- Abstract
Loading... -
+
P1.07-20 - Evaluation of the Efficacy of Continuing Nursing Education Sessions for Oncology Nurses at Princess Margaret Cancer Centre
09:45 - 09:45 | Presenter: Nazanin Nouriany | Author(s): Nicole Perera-Low, Pat Merante
- Abstract
Loading...
-
+
P1.09 - Pathology
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Pathology
-
+
P1.09-01 - Immunoprofiling Depends on Molecular Determinants to Predict Metastases and Target Therapy in Non-Small Cell Lung Carcinomas
09:45 - 09:45 | Presenter: Juliana Rugolo-Machado | Author(s): Alexandre Fabro, Cecilia Farhat, Edwin Parra, Vera Luiza Capelozzi
- Abstract
Loading... -
+
P1.09-02 - Comprehensive Genomic Profiling of Non-Small Cell Lung Cancer in Brazil (GBOT 0118/LACOG 0418)
09:45 - 09:45 | Presenter: Eldsamira Mascarenhas | Author(s): Ana Zimmer Gelatti Gelatti, Vladmir Cláudio Cordeiro De Lima, Luiz Henrique Araújo, Clarissa Baldotto, Clarissa Mathias, Mauro Zukin, Gustavo Werutsky, Paulo Ricardo Santos Nunes Filgo, Rafaela Jesus Gomes, Gilberto Castro
- Abstract
Loading... -
+
P1.09-03 - Clinicopathological Characteristics for NSCLC Harboring EGFR Exon 20 Insertion
09:45 - 09:45 | Presenter: Kei Morikawa | Author(s): Kazutaka Kakinuma, Takeo Inoue, Masamichi Mineshita
- Abstract
Loading... -
+
P1.09-04 - Comprehensive Genomic Profiling in a Brazilian Cohort of Lung Cancer Patients: Real-World Impact
09:45 - 09:45 | Presenter: Tiago Costa de Padua | Author(s): Mariana Ribeiro Monteiro, Marina Cavalcanti Maroja Silvino, Leticia Maria Neves de Carvalho, Tercia Tarciane Soares Sousa, Cinthia Leite Frizerra Borges Bognar, Eloa Brabo, Marcelo Rodrigo Frazão Campelo, Dayse Caroline de Magalhaes Limeira, Ana Beatriz Kinupe Abrahao, Mauro Zukin, Raphael Brandão Moreira, Luiz Henrique Araújo
- Abstract
Loading... -
+
P1.09-05 - ALK Testing in Chinese Advanced NSCLC Patients: A National-Wide Multicenter Prospective Real-World Data Study (The RATICAL Study)
09:45 - 09:45 | Presenter: Jianming Ying | Author(s): Lin Li, Wencai Li, Yuan Li, Qingxin Xia, Xiaodong Teng, Yueping Liu, Gang Chen, Xueshan Qiu, Wei Wu, Yuan Ji, Zheng Wang, Xiaochu Yan, Yuchen Han, a The Ratical Study Group
- Abstract
Loading... -
+
P1.09-06 - Evaluation of Molecular Testing in a Dutch Cohort of Metastatic Non-Small Cell Lung Cancer Patients from 2017
09:45 - 09:45 | Presenter: Chantal Kuijpers | Author(s): Michel Van Den Heuvel, Anne Van Lindert, Ronald Damhuis, Stefan Willems
- Abstract
Loading... -
+
P1.09-07 - The Clinical Utility and Performance of Whole-Exome Sequencing for NSCLC Patient Care: A Comparison to Standard-of-Care
09:45 - 09:45 | Presenter: Kenneth John O’Byrne | Author(s): Paul James Leo, Jonathan Ellis, Mhairi Clout, David Pennisi, Lisa Anderson, Lawrie Wheeler, Matthew Brown
- Abstract
Loading... -
+
P1.09-08 - Registration of Pre-Operative Lung Cancer PET/CT Scans with Post-Operative Histopathology Maps
09:45 - 09:45 | Presenter: Gabriel Reines March | Author(s): Xiangyang Ju, Stephen Marshall, Craig Dick, Stephen Harrow
- Abstract
Loading... -
+
P1.09-09 - Model to Predict Small Lymph Nodes Metastasis in Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Jiancheng Li | Author(s): Feiyang Su
- Abstract
Loading... -
+
P1.09-10 - Molecular Immunocytochemistry in Various NSCLC Samples Prepared as Non-Cell Block Cytology
09:45 - 09:45 | Presenter: Silvana Smojver-Ježek | Author(s): Božica Vrabec Branica, Vesna Šimić, Suzana Harabajsa, Ante Marušić, Sonja Badovinac, Sanja Pleština, Suzana Kukulj, Marko Jakopovic
- Abstract
Loading... -
+
P1.09-11 - Influences of Sampling Method to Morphological Feature Measurement of Lung Cancer Cell
09:45 - 09:45 | Presenter: Tomoharu Kiyuna | Author(s): Noriko Motoi, Hiroshi Yoshida, Shun-ichi Watanabe, Yuichiro Ohe, Atsushi Ochiai
- Abstract
Loading... -
+
P1.09-12 - In-Situ Hybridization Visual Scoring of Epigenetic Imprinting Genes Improves Early Diagnosis and Grading of Lung Cancers
09:45 - 09:45 | Presenter: Rex C Yung | Author(s): Tong Cheng, Xing Li, Xiaonan Wang, Han Si, Pengcheng Zhao, Rulong Shen, Jian Zhou, Hongyu Yu, Ming Ding, Shaohua Lu, Ning Zhou, Chunxue Bai
- Abstract
Loading... -
+
P1.09-13 - Prognostic Value of TMPRSS4 Expression and Its Role as Diagnostic Biomarker by Liquid Biopsy in Early Stage NSCLC
09:45 - 09:45 | Presenter: Francisco Exposito | Author(s): Maria Villalba, María José Pajares, Cristina Sainz, Ana Remirez, Eloisa Jantus, Carlos Camps, Luis M Montuenga, Ruben Pio, Carlos De Andrea, Alfonso Calvo
- Abstract
Loading... -
+
P1.09-14 - Comparison Between Liquid Biopsy and Conventional Tissue Biopsy in EGFR Genotyping of Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Sang Hoon Lee | Author(s): Eun Young Kim, Arum Kim, Taehee Kim, Yoon Soo Chang
- Abstract
Loading... -
+
P1.09-15 - Hybrid Organoid Reveals That Podoplanin-Positive Cancer-Associated Fibroblasts Enhance Proliferation of Lung Cancer Cell
09:45 - 09:45 | Presenter: Hiroshi Nakamura | Author(s): Masato Sugano, Tomoyuki Miyashita, Hiroko Hashimoto, Atsushi Ochiai, Kenji Suzuki, Masahiro Tsuboi, Genichiro Ishii
- Abstract
Loading... -
+
P1.09-16 - Tumor Proliferation Is Associated with the Tumor Immunological Status: A Study on NSCLC Using Multiplex Immunofluorescence
09:45 - 09:45 | Presenter: Andreas Spitzmüller | Author(s): Tze Heng Tan, Michael Joseph Surace, Lorenz Rognoni, David Chain, Vinay Pawar, Jaime Rodriguez Canales
- Abstract
Loading... -
+
P1.09-17 - In the Minimally Invasive Era, What Is the Role of Intra-Operative Frozen Section Prior to Lobectomy: A Single Institution Perspective
09:45 - 09:45 | Presenter: Ashok Kar | Author(s): Akshay Patel, Brendan Tinwell, Ian Hunt
- Abstract
Loading... -
+
P1.09-18 - Small-Sized Spread Through Air Spaces (STAS) in Resected Pulmonary Adenocarcinoma: Is It Necessary to Record It as a Prognostic Factor?
09:45 - 09:45 | Presenter: Akihiko Yoshizawa | Author(s): Kyoko Kondo, Naoki Nakajima
- Abstract
Loading... -
+
P1.09-19 - High-Throughput Next Generation Sequencing of Treatment-Naïve Non-Squamous NSCLC: The Singapore National Lung Profiling Study
09:45 - 09:45 | Presenter: Aaron C Tan | Author(s): Gillianne Lai, Gek San Tan, Shou Yu Poon, Brett Doble, Tse Hui Lim, Zaw Win Aung, Angela Takano, Wan Ling Tan, Mei Kim Ang, Bien Soo Tan, Anantham Devanand, Chow Wei Too, Apoorva Gogna, Boon Hean Ong, Tina Koh, Ravindran Kanesvaran, Quan Sing Ng, Amit Jain, Tanujaa Rajasekaran, Alvin Lim, Wan Teck Lim, Chee Keong Toh, Eng Huat Tan, Kiat Hon Lim, Daniel SW Tan
- Abstract
Loading... -
+
P1.09-20 - Significance of Maximal Diameter Measurement in Small-Sized Adenocarcinomas
09:45 - 09:45 | Presenter: Hironori Ninomiya | Author(s): Junji Ichinose, Yosuke Matsuura, Masayuki Nakao, Mingyon Mun, Makoto Nishio, Sakae Okumura, Yuichi Ishikawa
- Abstract
Loading... -
+
P1.09-21 - Tumor Responses Based on Tumor Growth Rate During PD-1 Inhibitor Therapy in Advanced Non-Small-Cell Lung Cancer Patients
09:45 - 09:45 | Presenter: Daan P. Hurkmans | Author(s): Deirdre MHJ Ten Berge, Ilse Den Besten, Jeroen S Kloover, Ron H.J. Mathijssen, Reno Debets, Joachim G.J.V. Aerts, Egbert F Smit
- Abstract
Loading... -
+
P1.09-22 - Programmed Death Ligand-1 Expression in Non-Small Cell Lung Cancer in Mexican Population and Correlation with Clinicopathologic Features
09:45 - 09:45 | Presenter: Omar Eleazar Macedo-Perez | Author(s): Leticia Bornstein, Ivan Lyra Gonzalez, Claudia Bautista-Wong, Jesus Cienfuegos-Meza, Katya Campos-Peralta, Edgardo Jimenez-Fuentes
- Abstract
Loading... -
+
P1.09-23 - A33 and SATB2 Immunohistochemistry for Differentiating Metastatic Colorectal Carcinoma from Pulmonary Enteric Adenocarcinoma
09:45 - 09:45 | Presenter: Likun Hou | Author(s): Chunyan Wu, Wei Zhang, Junhong Guo
- Abstract
Loading... -
+
P1.09-24 - Tumor Necrosis Correlates with PD-L1 and PD-1 Expression in Lung Adenocarcinoma
09:45 - 09:45 | Presenter: Judit Moldvay | Author(s): Vanda Téglási, Orsolya Pipek, Lívia Rojkó, Tibor Glasz, Attila Vágvölgyi, Ilona Kovalszky, Márton Gyulai, Zoltán Lohinai, Erzsébet Rásó, József Tímár, Balázs Döme, Zoltán Szállási, Lilla Reiniger
- Abstract
Loading... -
+
P1.09-25 - The Use of In-Situ RNA Analysis in the Detection of Metastatic HPV Mediated Squamous Cell Carcinoma to the Lung with p16 Correlation
09:45 - 09:45 | Presenter: Roula Katerji | Author(s): Deborah Mulford, Moises J. Velez
- Abstract
Loading... -
+
P1.09-26 - Prevalence of PD-L1 Expression Rates in Different NSCLC Specimens
09:45 - 09:45 | Presenter: Wendy Cooper | Author(s): Mikaela Holmes, Annabelle Mahar, Trina Lum, Michael Boyer, Steven Kao
- Abstract
Loading... -
+
P1.09-27 - Interobserver Variation in the Cytological Diagnosis of Pulmonary Adenocarcinoma Presenting with Ground-Glass Opacity Nodules
09:45 - 09:45 | Presenter: Heae Surng Park | Author(s): Ju Yeon Pyo, Soon Won Hong, Min-sun Cho, Yoonjin Cha
- Abstract
Loading... -
+
P1.09-28 - A Significant Discordance Between PANAMutyper™ and Targeted Deep Sequencing for Detecting EGFR Mutation in NSCLC
09:45 - 09:45 | Presenter: Jeonghyo Lee | Author(s): Song Kook Lee, Yeon Bi Han, Hyun Jung Kwon, Hyojin Kim, Jin-Haeng Chung
- Abstract
Loading... -
+
P1.09-30 - Molecular Characterization of Preinvasive and Invasive Lesions in Multifocal Pulmonary Adenocarcinomas
09:45 - 09:45 | Presenter: Hsiang-Ling Ho | Author(s): Yi-Chen Yeh, Teh-Ying Chou
- Abstract
Loading... -
+
P1.09-31 - Clinicopathological Features and Genomic Profiling of Pulmonary Blastoma with High-Grade Fetal Adenocarcinoma Component
09:45 - 09:45 | Presenter: Jikai Zhao | Author(s): Chan Xiang, Pengjiao Wang, Ping Guo, Jingjing Zheng, Han Han-Zhang, Keke Yu, Ruiying Zhao, Jie Zhang, Yuchen Han
- Abstract
Loading... -
+
P1.09-32 - Concurrent Genomic Alterations in ALK-Rearranged Non-Small Cell Lung Cancer Patients
09:45 - 09:45 | Presenter: Sergi Clavé | Author(s): Marta Salido, Joan Gibert, Max Hardy-Werbin, Elizabeth Weingartner, James Hernandez, Donna Nichol, Pedro Rocha, Xènia Riera, REmedios Blanco, Joaquim Bosch-Barrera, Álvaro Taus, Lara Pijuan, Beatriz Bellosillo, Edurne Arriola
- Abstract
Loading... -
+
P1.09-33 - More than 40% of Locally Advanced or Metastatic NSCLC Patients Without EGFR/ALK Alterations Have PD-L1 TPS >= 1% in China
09:45 - 09:45 | Presenter: Shiyue Zhang | Author(s): Suqin Ben, Xuedong Pan, Shiwang Wen, Yuanzhu Jiang, Jun Guo, Xinglong Fan, Yi Dai, Donglin Chen, Kai Wang, Xiaowei Dong
- Abstract
Loading...
-
+
P1.10 - Prevention and Tobacco Control
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Prevention and Tobacco Control
-
+
P1.10-01 - Patterns of Birth Cohort-Specific Smoking Histories by Race and Ethnicity in the US, 1965-2017
09:45 - 09:45 | Presenter: Rafael Meza | Author(s): Pianpian Cao, Jihyoun Jeon, Theodore R Holford
- Abstract
Loading... -
+
P1.10-02 - Role Models and Lung Cancer Awareness: Does It Change the Mind-Set and Perception of General Population?
09:45 - 09:45 | Presenter: Deepak Saini | Author(s): Meghal Khanna, ANUSHA Dubey, Shubham Roy, Abhishek Shankar
- Abstract
Loading... -
+
P1.10-03 - Gut Microbiota and Lung Cancer: A Mendelian Randomisation Study
09:45 - 09:45 | Presenter: Huaqiang Zhou | Author(s): Jiaqing Liu, Yaxiong Zhang, Wenfeng Fang, Yunpeng Yang, Shaodong Hong, Yan Huang, Li Zhang
- Abstract
Loading... -
+
P1.10-04 - Lung Cancer in Patients with HIV Disease - Unique Clinical and Biomarker Features Impacting Lung Cancer Screening and Management
09:45 - 09:45 | Presenter: Balazs Halmos | Author(s): Shirin Attarian, Xiaoling Guo, Brian Ko, Aditi Singh, Enrico Castellucci, Rasim Gucalp, Missak Haigentz, Haiying Cheng
- Abstract
Loading... -
+
P1.10-05 - Tobacco Retail Availability and Tobacco Cessation Among Lung Cancer Survivors
09:45 - 09:45 | Presenter: Geoffrey Liu | Author(s): Lawson Eng, Jie Su, Katrina Hueniken, M Catherine Brown, Andrew Hope, Andrea Bezjak, Adrian G Sacher, Penelope A Bradbury, Frances Shepherd, Natasha B Leighl, Andrew F Pierre, Peter Selby, David P Goldstein, Wei Xu, Meredith E Giuliani, William K. Evans, Michael Chaiton
- Abstract
Loading... -
+
P1.10-06 - Pathological Characterization of Radon-Induced Lung Cancer in Rats
09:45 - 09:45 | Presenter: Laura Mezquita | Author(s): Julien Adam, David Planchard, CECILE Jovelet, Etienne Rouleau, Edouard Auclin, CHARLES Naltet, pernelle Lavaud, LUDOVIC Lacroix, Sylvie Chevillard, Benjamin Besse
- Abstract
Loading... -
+
P1.10-07 - Characteristics of Current and Former Smokers Who Acknowledge Their Risk of Lung Cancer: Results from the EDIFICE6 Survey
09:45 - 09:45 | Presenter: Jean-Francois Morère | Author(s): Sébastien Couraud, Laurent Greillier, Thibault De La Motte Rouge, Chantal Touboul, Christine Lhomel, Jérome Viguier, François Eisinger, Morgan Roupret
- Abstract
Loading... -
+
P1.10-08 - The Usefulness of Inpatient Smoking Cessation Program at Single Cancer Center
09:45 - 09:45 | Presenter: In-Jae Oh | Author(s): Ha-Young Park, Cheol-Kyu Park, Hong-Joon Shin, Yu-Il Kim, Young-Chul Kim, Yu Ri Choe, Sun-Seog Kweon
- Abstract
Loading... -
+
P1.10-09 - Cessation Rates of an Expanded Pharmacy-Driven Smoking Cessation Program
09:45 - 09:45 | Presenter: Catherine E Burdalski | Author(s): Zirah Acosta, Bryna Ewachiw, Josephine Feliciano, Stacy Dalpoas, Samantha Myers
- Abstract
Loading... -
+
P1.10-10 - Social Vulnerability and Survival in Lung Cancer in Emerging Country
09:45 - 09:45 | Presenter: Ricardo Mingarini Terra | Author(s): Priscila Berenice Costa, Taires Santos Silva, Karina de Cássia Braga Ribeiro, Paulo Manuel Pêgo Fernandes
- Abstract
Loading... -
+
P1.10-11 - Examination of Lifestyle Factors and Associations with Genetic Mutations in Lung Cancer Cases
09:45 - 09:45 | Presenter: Marisa Bittoni | Author(s): Randall Harris, Rajeswara Rao Arasada, David P Carbone
- Abstract
Loading...
-
+
P1.11 - Screening and Early Detection
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Screening and Early Detection
-
+
P1.11-01 - The Implementation of the Lung-RADS ™ in Pilot Silesian Study with LDCT - An Opportunity for Better Control of Overdiagnosis
09:45 - 09:45 | Presenter: Ewa Wachula | Author(s): Sylwia Szablowska-Siwik, Damian Czyzewski, Mariusz Adamek
- Abstract
Loading... -
+
P1.11-02 - Acceleration of Lung Cancer Diagnosis: Utility Study for AI-Based Stratification of Pulmonary Nodules
09:45 - 09:45 | Presenter: Timor Kadir | Author(s): Lyndsey C Pickup, Carlos Arteta, Jerome Declerck, Petr Novotny, Sanja L Antic, Aneri B Balar, Pierre P Massion
- Abstract
Loading... -
+
P1.11-03 - Disparities and National Lung Cancer Screening Guidelines in the U.S. Population
09:45 - 09:45 | Presenter: Summer S Han | Author(s): Eric Chow, Kevin Ten Haaf, Iakovos Toumazis, Mehrad Bastani, Martin Tammemagi, Jihyoun Jeon, Eric Feuer, Rafael Meza, Sylvia Katina Plevritis
- Abstract
Loading... -
+
P1.11-04 - Utilizing DNA Repair Activity Biomarkers for Lung Cancer Risk Assessment and Early Detection
09:45 - 09:45 | Presenter: Tamar Paz-Elizur | Author(s): Yael Leitner-Dagan, Kerstin B. Meyer, Barak Markus, Federico M. Giorgi, Martin O’reilly, Hyunjin Kim, Yentl Evgy, Ronen Fluss, Laurence S. Freedman, Robert C Rintoul, Bruce Ponder, Zvi Livneh
- Abstract
Loading... -
+
P1.11-05 - Genetic Architecture of Lung Cancer Using Machine-Learning Approaches in Genome-Wide Association Studies
09:45 - 09:45 | Presenter: Jinyoung Byun | Author(s): Younghun Han, Jacob Edelson, Quinn Ostrom, Christopher Ian Amos
- Abstract
Loading... -
+
P1.11-06 - Expanding Criteria for Lung Cancer Screening Reduces Gender Disparity
09:45 - 09:45 | Presenter: Mary M. Pasquinelli | Author(s): Kevin L. Kovitz, Marianne Durham, James Zacny, Zane Deliu, Kayleigh Rygalski, Li Liu, Matthew Koshy, Robert Winn, Lawrence Eric Feldman
- Abstract
Loading... -
+
P1.11-07 - CfDNA from Bronchoalveolar Lavage Fluid for the Identification of Solid Pulmonary Nodules: A New Medium of Liquid Biopsy
09:45 - 09:45 | Presenter: Junhong Jiang | Author(s): Chuanyong Mu, Jun Zhao, Daxiong Zeng, Changguo Wang, Haiyan Li, Junyi Ye, Tengfei Zhang
- Abstract
Loading... -
+
P1.11-08 - Are Risk Prediction Models Superior Over Standard Criteria for Lung Cancer Screening in Europe? Macroscale Simulation on Large Polish Cohort
09:45 - 09:45 | Presenter: Marcin Ostrowski | Author(s): Tomasz Marjanski, Robert Dziedzic, Szymon Kocot, Witold Rzyman
- Abstract
Loading... -
+
P1.11-09 - Risk of Second Primary Malignancy After Non-Small-Cell Lung Cancer: A Competing Risk Nomogram Based on the SEER Database
09:45 - 09:45 | Presenter: Jiayi Shen | Author(s): Huaqiang Zhou, Yaxiong Zhang, Yan Huang, Wenfeng Fang, Yunpeng Yang, Shaodong Hong, Gang Chen, Shen Zhao, Xi Chen, Zhonghan Zhang, Jiaqing Liu, Wei Xian, Yuanyuan Zhao, Xue Hou, Yuxiang Ma, Ting Zhou, Hongyun Zhao, Li Zhang
- Abstract
Loading... -
+
P1.11-10 - Serum MicroRNA Biomarkers for Screening of Resectable Lung Cancer
09:45 - 09:45 | Presenter: Keisuke Asakura | Author(s): Tsukasa Kadota, Juntaro Matsuzaki, Yukihiro Yoshida, Kazuo Nakagawa, Hisao Asamura, Shun-ichi Watanabe, Takahiro Ochiya
- Abstract
Loading... -
+
P1.11-11 - Initial Discovery of Exhaled Small Polar Energetics-Related Metabolites by GC-MS for Lung Cancer Risk Assessment
09:45 - 09:45 | Presenter: Simon D Spivack | Author(s): Miao Kevin Shi, Dhruv Patel, Aditi Desai, Jay Dobkin, Chirag Shah, Dean Hosgood, Kenny Ye, Yunping Qiu, Irwin Kurland
- Abstract
Loading... -
+
P1.11-12 - Genetic Landscape and Immune Microenvironment Features in Recurrence in Stage IA of Lung Adenocarcinoma
09:45 - 09:45 | Presenter: Lu Yang | Author(s): Jing Zhang, Haiyan Xu, Guangjian Yang, Fei Xu, Yane Song, Xinying Shi, Lijia Wu, Henghui Zhang, Jianming Ying, Yan Wang
- Abstract
Loading... -
+
P1.11-13 - Mass Spectrometry Proteomics Analysis Discovers Biomarkers in Serum Months to Years Before Non-Small Cell Lung Cancer: The HUNT Study
09:45 - 09:45 | Presenter: Olav Toai Duc Nguyen | Author(s): Maria Markaki, Animesh Sharma, Christina Chatzipantsiou, Vincenzo Lagani, Ioannis Tsamardinos, Oluf Dimitri Røe
- Abstract
Loading... -
+
P1.11-14 - SGLT2 Is a Diagnostic and Therapeutic Target for Early-Stage Lung Adenocarcinoma
09:45 - 09:45 | Presenter: Claudio Scafoglio | Author(s): Brendon Villegas, Eva Jolanthe Koziolek, Jie Liu, Jorge Barrio, W. Dean Wallace, David Elashoff, Denise Aberle, Jane Yanagawa, David Shackelford, Steven Dubinett
- Abstract
Loading... -
+
P1.11-15 - Feasibility of a Lung Health Clinic for Early Lung Cancer Identification in High-Risk Individuals in South-East London
09:45 - 09:45 | Presenter: Gillian Selman | Author(s): Arjun Nair, Azhar Saleem, Helen Kerslake, Ronan Breen, Sophia Ho, Sze Mun Mak, Yvonne Akande, Jo Turville, Tiago Duarte de Oliveira Rua, Janet Peacock, George Santis, Reza Razavi
- Abstract
Loading... -
+
P1.11-16 - Squamous Cell Lung Cancer Risk Is Associated with Rare, Pathogenic Germline Variants in BRCA2 and Fanconi Anemia Genes
09:45 - 09:45 | Presenter: Zeynep H Gumus | Author(s): Myvizhi Esai Selvan, Robert Klein
- Abstract
Loading... -
+
P1.11-17 - Osteoporosis, Coronary Artery Calcification, and COPD in a Lung Cancer Screening Cohort
09:45 - 09:45 | Presenter: James Finigan | Author(s): Katherine Lowe, Cameron Thiele, Carla Wilson, Stephen Humphries, David Lynch, Elizabeth Regan
- Abstract
Loading... -
+
P1.11-18 - The Results of Mandatory Smoking Cessation Intervention in a Population-Based Lung Cancer Screening Trial
09:45 - 09:45 | Presenter: Eunju Lee | Author(s): Yeol Kim, Jaeho Lee, Juntae Lim, Hyae Young Kim, Jin Mo Goo, Choon Taek Lee, Seung Hun Jang, Won Chul Lee, Sook Whan Sung, Chan Wha Lee, Kui Son Choi, Boyoung Park, Duk Hyoung Lee
- Abstract
Loading... -
+
P1.11-19 - Trial in Progress: Cancer Screening Study With or Without Low Dose Lung CT to Validate a Multi-Cancer Early Detection Blood Test
09:45 - 09:45 | Presenter: Sam Janes | Author(s): Jennifer L. Dickson, Anand Devaraj, Carolyn Horst, Samantha L Quaife, Claire Levermore, Kylie Gyertson, Anne-Marie Mullin, Laura Farrelly, Brian Allen, Nan Zhang, Christina Clarke, Stephanie Hamilton, Anne-Renee Hartman, Allan Hackshaw
- Abstract
Loading... -
+
P1.11-20 - Identification of a Thirteen-Gene Prognostic Signature for Lung Adenocarcinoma
09:45 - 09:45 | Presenter: Yang Wo | Author(s): Yuanyong Wang, Tong Lu, Wenjie Jiao
- Abstract
Loading... -
+
P1.11-21 - Liverpool Health Lung Project: Significant Incidental Findings in a Smoker-Predominant Cohort
09:45 - 09:45 | Presenter: Martin Ledson | Author(s): Yue Ivy Cheng, Edward Gaynor, John Kirkpatrick Field
- Abstract
Loading... -
+
P1.11-22 - Lung Cancer Growth: Impact of Different Assumptions
09:45 - 09:45 | Presenter: David Yankelevitz | Author(s): Maham Siddique, Rowena Yip, Claudia I Henschke
- Abstract
Loading... -
+
P1.11-23 - The Impact of the Family History of Different Cancers on Lung Cancer
09:45 - 09:45 | Presenter: Jianfu Li | Author(s): Caichen Li, Bo Cheng, Jianxing He, Wenhua Liang
- Abstract
Loading... -
+
P1.11-24 - Implementation of an Organized Lung Cancer Screening Program in Korea
09:45 - 09:45 | Presenter: Yeol Kim
- Abstract
Loading... -
+
P1.11-25 - Adjustment for Lead-Time Bias and Over-Diagnosis in Lung Cancer Screening
09:45 - 09:45 | Presenter: Szu-Chun Yang | Author(s): Jung-Der Wang
- Abstract
Loading... -
+
P1.11-26 - The Epidemiology of Ground Glass Opacity (GGO) Lung Adenocarcinoma: A Network Based Cumulative Meta-Analysis
09:45 - 09:45 | Presenter: Xiongfei Li | Author(s): Yanye Wang, Shikang Zhao, Jun Chen, Song Xu
- Abstract
Loading... -
+
P1.11-27 - Computed Tomography Screening for Early Lung Cancer, COPD and Cardiovascular Disease in Shanghai: Rationale and Design of a Population-Based Comparative Study
09:45 - 09:45 | Presenter: Yihui Du | Author(s): Qiong Li, Grigory Sidorenkov, Marleen Vonder, Jiali Cai, Geertruida H. De Bock, Mieneke Rook, Rozemarijn Vliegenthart, Marjolein A. Heuvelmans, Monique D. Dorrius, Harry JM Groen, Pim van Der Harst, Zhaoxiang Ye, Xueqian Xie, Wenjing Wang, Matthijs Oudkerk, Shiyuan Liu
- Abstract
Loading... -
+
P1.11-28 - Lung Cancer: Susceptibility and Survival Differences for Women and Men
09:45 - 09:45 | Presenter: Claudia I Henschke | Author(s): Rowena Yip, Esther Fevrier, Andrea Wolf, Natthaya Triphuridet
- Abstract
Loading... -
+
P1.11-29 - Relationship Between Lung Cancer Screening Centers in the United States and High-Risk Individuals
09:45 - 09:45 | Presenter: Candice Leigh Wilshire | Author(s): Claire Henson, Shih Chiu, Christopher Gilbert, Eric Vallieres, Jed Gorden
- Abstract
Loading... -
+
P1.11-30 - Very Rapid Growth of Small Pulmonary Nodules Predicts Benignity
09:45 - 09:45 | Presenter: Joseph Barnett | Author(s): Ilaria Pulzato, Toby Burn, Sara Zafar, Julia Hine, Emily Bartlett, Pallav Shah, Andrew G Nicholson, Carole Ridge, Simon Padley, Philip L Molyneaux, Samuel Kemp, Anand Devaraj
- Abstract
Loading... -
+
P1.11-31 - Understanding Referral Patterns in a Lung Cancer Screening Program
09:45 - 09:45 | Presenter: Diane Nabil Haddad | Author(s): Alexis Paulson, Suraj Kapoor, Douglas Conway, Pierre P Massion, Kim Lori Sandler, Steve Deppen
- Abstract
Loading... -
+
P1.11-32 - The UKLS Nodule Risk Model (UKLS-NRM): Utilising Nodule Volumetry
09:45 - 09:45 | Presenter: John Kirkpatrick Field | Author(s): Michael W. Marcus, Stephen W. Duffy, Anand Devaraj, Matthijs Oudkerk, David R. Baldwin
- Abstract
Loading... -
+
P1.11-33 - Prognostic Value of Symptoms at Lung Cancer Diagnosis: A Two-Year Observational Study
09:45 - 09:45 | Presenter: Dinora Polanco | Author(s): Ana Mas, Sandra Bertran, Gemma Fierro, Asuncion Seminario, Silvia Gomez, Ferran Barbé
- Abstract
Loading... -
+
P1.11-34 - The Liverpool Healthy Lung Project – Championing the Importance of Lung Health
09:45 - 09:45 | Presenter: Martin Ledson | Author(s): Mohammed Ahmed, Rachel Arvanitis, Michelle Timoney, Edward Gaynor, John Kirkpatrick Field
- Abstract
Loading... -
+
P1.11-35 - Comparison of Lung Cancer Screening Trials from East Asia; South Korea, Japan, and Taiwan
09:45 - 09:45 | Presenter: Sang Won Shin
- Abstract
Loading... -
+
P1.11-36 - A Simple Tool to Prioritize US Ever-Smokers for CT Screening Eligibility Assessment
09:45 - 09:45 | Presenter: Hilary Robbins | Author(s): Li Cheung, Mat Callister, Philip Crosbie, Florence Guida, Christine Dorothy Berg, Paul Brennan, Hormuzd Katki, Mattias Johansson
- Abstract
Loading... -
+
P1.11-37 - Face Your Fear Awareness Campaign
09:45 - 09:45 | Presenter: Lorraine Shona Dallas | Author(s): Rachel Avery
- Abstract
Loading... -
+
P1.11-38 - Frequency and Prognostic Impact of Concomitant Mutations in KRAS and TP53 or STK11 in Brazilian Lung Adenocarcinoma Patients
09:45 - 09:45 | Presenter: Vladmir Cláudio Cordeiro De Lima | Author(s): Vanessa Karen De Sa, Juliano Prudencio Chinoca, mauro daniel Spina Donadio, Giovana Tardin Torrezan, DIRCE MARIA Carraro, Helano C. Freitas
- Abstract
Loading... -
+
P1.11-39 - Low-Dose CT Lung Screening: Data Analysis of Lung Cancer Patients with Above 40 Years Old
09:45 - 09:45 | Presenter: Yujing Jin | Author(s): Ning Wu
- Abstract
Loading... -
+
P1.11-40 - Systematic Development and Multi-Cohort Validation of a Serum miRNA Biomarker Panel for Detection of Early Stage Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Lihan Zhou | Author(s): Ruiyang Zou, Lisha Ying, Dan Su, John Tam, Weimin Mao, Heng-Phon Too
- Abstract
Loading...